Home Other Building Blocks Terfenadine

Terfenadine

CAS No.:
50679-08-8
Catalog Number:
AG003UIK
Molecular Formula:
C32H41NO2
Molecular Weight:
471.6734
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
500mg
≥98%
1 week
United States
$91
- +
1g
≥98%
1 week
United States
$116
- +
5g
≥98%
1 week
United States
$154
- +
Product Description
Catalog Number:
AG003UIK
Chemical Name:
Terfenadine
CAS Number:
50679-08-8
Molecular Formula:
C32H41NO2
Molecular Weight:
471.6734
MDL Number:
MFCD00079622
IUPAC Name:
1-(4-tert-butylphenyl)-4-[4-[hydroxy(diphenyl)methyl]piperidin-1-yl]butan-1-ol
InChI:
InChI=1S/C32H41NO2/c1-31(2,3)26-18-16-25(17-19-26)30(34)15-10-22-33-23-20-29(21-24-33)32(35,27-11-6-4-7-12-27)28-13-8-5-9-14-28/h4-9,11-14,16-19,29-30,34-35H,10,15,20-24H2,1-3H3
InChI Key:
GUGOEEXESWIERI-UHFFFAOYSA-N
SMILES:
OC(c1ccc(cc1)C(C)(C)C)CCCN1CCC(CC1)C(c1ccccc1)(c1ccccc1)O
EC Number:
256-710-8
Properties
Complexity:
582  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
471.314g/mol
Formal Charge:
0
Heavy Atom Count:
35  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0
Molecular Weight:
471.685g/mol
Monoisotopic Mass:
471.314g/mol
Rotatable Bond Count:
9  
Topological Polar Surface Area:
43.7A^2
Undefined Atom Stereocenter Count:
1  
Undefined Bond Stereocenter Count:
0
XLogP3:
6.6  
Literature
Title Journal
Mechanism of As2O3-Induced Action Potential Prolongation and Using hiPS-CMs to Evaluate the Rescue Efficacy of Drugs With Different Rescue Mechanism. Toxicological sciences : an official journal of the Society of Toxicology 20170801
Observations on conducting whole-cell patch clamping of the hERG cardiac K(+) channel in pure human serum. Journal of applied toxicology : JAT 20170401
Why Can dl-Sotalol Prolong the QT Interval In Vivo Despite Its Weak Inhibitory Effect on hERG K(+) Channels In Vitro? Electrophysiological and Pharmacokinetic Analysis with the Halothane-Anesthetized Guinea Pig Model. Cardiovascular toxicology 20160401
H1-antihistamines exacerbate high-fat diet-induced hepatic steatosis in wild-type but not in apolipoprotein E knockout mice. American journal of physiology. Gastrointestinal and liver physiology 20140715
Availability of human induced pluripotent stem cell-derived cardiomyocytes in assessment of drug potential for QT prolongation. Toxicology and applied pharmacology 20140701
Chronic ingestion of H1-antihistamines increase progression of atherosclerosis in apolipoprotein E-/- mice. PloS one 20140101
Early identification of clinically relevant drug interactions with the human bile salt export pump (BSEP/ABCB11). Toxicological sciences : an official journal of the Society of Toxicology 20131201
Activity, inhibition, and induction of cytochrome P450 2J2 in adult human primary cardiomyocytes. Drug metabolism and disposition: the biological fate of chemicals 20131201
Refining the human iPSC-cardiomyocyte arrhythmic risk assessment model. Toxicological sciences : an official journal of the Society of Toxicology 20131201
Validation of visualized transgenic zebrafish as a high throughput model to assay bradycardia related cardio toxicity risk candidates. Journal of applied toxicology : JAT 20121001
Involvement of serine protease and proteinase-activated receptor 2 in dermatophyte-associated itch in mice. The Journal of pharmacology and experimental therapeutics 20121001
H(1)-antihistamines and urticaria: how can we predict the best drug for our patient? Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 20121001
Negative electro-mechanical windows are required for drug-induced Torsades de Pointes in the anesthetized guinea pig. Journal of pharmacological and toxicological methods 20120901
Effect of intestinal first-pass hydrolysis on the oral bioavailability of an ester prodrug of fexofenadine. Journal of pharmaceutical sciences 20120901
Synthesis of betulinic acid derivatives as entry inhibitors against HIV-1 and bevirimat-resistant HIV-1 variants. Bioorganic & medicinal chemistry letters 20120815
Optimization of 4-aminoquinoline/clotrimazole-based hybrid antimalarials: further structure-activity relationships, in vivo studies, and preliminary toxicity profiling. Journal of medicinal chemistry 20120809
Quantification of fexofenadine in biological matrices: a review of bioanalytical methods. Biomedical chromatography : BMC 20120801
Exploring novel colon-targeting antihistaminic prodrug for colitis. Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 20120801
Cathepsin E induces itch-related response through the production of endothelin-1 in mice. European journal of pharmacology 20120705
Microdosing clinical study: pharmacokinetic, pharmacogenomic (SLCO2B1), and interaction (grapefruit juice) profiles of celiprolol following the oral microdose and therapeutic dose. Journal of clinical pharmacology 20120701
Mouse model of touch-evoked itch (alloknesis). The Journal of investigative dermatology 20120701
Development of recombinant cell line co-expressing mutated Nav1.5, Kir2.1, and hERG for the safety assay of drug candidates. Journal of biomolecular screening 20120701
Enhanced systemic exposure of fexofenadine via the intranasal administration of chitosan-coated liposome. International journal of pharmaceutics 20120701
Long-lasting inhibition of the intestinal absorption of fexofenadine by cyclosporin A in rats. Journal of pharmaceutical sciences 20120701
Influence of Panax ginseng on cytochrome P450 (CYP)3A and P-glycoprotein (P-gp) activity in healthy participants. Journal of clinical pharmacology 20120601
The impact of P-glycoprotein mediated efflux on absorption of 11 sedating and less-sedating antihistamines using Caco-2 monolayers. Xenobiotica; the fate of foreign compounds in biological systems 20120601
Does terfenadine-induced ventricular tachycardia/fibrillation directly relate to its QT prolongation and Torsades de Pointes? British journal of pharmacology 20120601
An overview of bilastine metabolism during preclinical investigations. Drug and chemical toxicology 20120601
Whole-cell configuration of the patch-clamp technique in the hERG channel assay to predict the ability of a compound to prolong QT interval. Current protocols in pharmacology 20120601
Enhancement of clara cell 10-kD protein (CC10) production from nasal epithelial cells by fexofenadine hydrochloride. Asian Pacific journal of allergy and immunology 20120601
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions. Journal of medicinal chemistry 20120524
The electro-mechanical window in anaesthetized guinea pigs: a new marker in screening for Torsade de Pointes risk. British journal of pharmacology 20120501
Intestinal OATP1A2 inhibition as a potential mechanism for the effect of grapefruit juice on aliskiren pharmacokinetics in healthy subjects. European journal of clinical pharmacology 20120501
Effects of single therapeutic doses of promethazine, fexofenadine and olopatadine on psychomotor function and histamine-induced wheal- and flare-responses: a randomized double-blind, placebo-controlled study in healthy volunteers. Archives of dermatological research 20120501
Identifying a selective substrate and inhibitor pair for the evaluation of CYP2J2 activity. Drug metabolism and disposition: the biological fate of chemicals 20120501
Involvement of leukotriene B4 in itching in a mouse model of ocular allergy. Experimental eye research 20120501
Characterization of A-935142, a hERG enhancer, in the presence and absence of standard hERG blockers. Life sciences 20120420
Preseasonal prophylactic treatment with antihistamines suppresses IL-5 but not IL-33 mRNA expression in the nasal mucosa of patients with seasonal allergic rhinitis caused by Japanese cedar pollen. Acta oto-laryngologica 20120401
Different effects of the selective serotonin reuptake inhibitors fluvoxamine, paroxetine, and sertraline on the pharmacokinetics of fexofenadine in healthy volunteers. Journal of clinical psychopharmacology 20120401
Structure determination of fexofenadine-α-cyclodextrin complex by quantitative 2D ROESY analysis and molecular mechanics studies. Magnetic resonance in chemistry : MRC 20120401
In vitro-in situ permeability and dissolution of fexofenadine with kinetic modeling in the presence of sodium dodecyl sulfate. European journal of drug metabolism and pharmacokinetics 20120301
Carbamazepine differentially affects the pharmacokinetics of fexofenadine enantiomers. British journal of clinical pharmacology 20120301
A randomized control trail of stepwise treatment with fluticasone propionate nasal spray and fexofenadine hydrochloride tablet for seasonal allergic rhinitis. Allergology international : official journal of the Japanese Society of Allergology 20120301
Pharmacophore modeling for hERG channel facilitation. Biochemical and biophysical research communications 20120203
Inhibition of HERG1 K+ channel protein expression decreases cell proliferation of human small cell lung cancer cells. Pflugers Archiv : European journal of physiology 20120201
The effects of an H3 receptor antagonist (PF-03654746) with fexofenadine on reducing allergic rhinitis symptoms. The Journal of allergy and clinical immunology 20120201
Ketoconazole-associated preferential increase in dopamine D2 receptor occupancy in striatum compared to pituitary in vivo: role for drug transporters? Journal of clinical psychopharmacology 20120201
Treatment of acquired perforating dermatosis with cantharidin. Archives of dermatology 20120201
Salinomycin inhibits prostate cancer growth and migration via induction of oxidative stress. British journal of cancer 20120103
Noninvasive evaluation of contractile behavior of cardiomyocyte monolayers based on motion vector analysis. Tissue engineering. Part C, Methods 20120101
Spectrofluorimetric determination of etodolac, moxepril HCl and fexofenadine HCl using europium sensitized fluorescence in bulk and pharmaceutical preparations. Journal of fluorescence 20120101
Effects of bepotastine and fexofenadine on histamine-induced flare, wheal and itch. International archives of allergy and immunology 20120101
The PI3-kinase/mTOR-targeting drug NVP-BEZ235 inhibits growth and IgE-dependent activation of human mast cells and basophils. PloS one 20120101
Toward a New Gold Standard for Early Safety: Automated Temperature-Controlled hERG Test on the PatchLiner. Frontiers in pharmacology 20120101
Incidence and risk of QTc interval prolongation among cancer patients treated with vandetanib: a systematic review and meta-analysis. PloS one 20120101
Histamine H1 antagonists and clinical characteristics of febrile seizures. International journal of general medicine 20120101
Adaptation and validation of the Urticaria Patient Daily Diary for adolescents. Allergy and asthma proceedings 20120101
Phenytoin in treatment of amiodarone-induced Torsades de pointes. Indian journal of pharmacology 20120101
Spectrophotometric Determination of Mycophenolate Mofetil as Its Charge-Transfer Complexes with Two π-Acceptors. Journal of analytical methods in chemistry 20120101
Mechanisms, risk factors, and management of acquired long QT syndrome: a comprehensive review. TheScientificWorldJournal 20120101
In vitro model for assessing arrhythmogenic properties of drugs based on high-resolution impedance measurements. Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 20120101
Development and validation of an automated high-throughput system for zebrafish in vivo screenings. PloS one 20120101
Drug discovery models and toxicity testing using embryonic and induced pluripotent stem-cell-derived cardiac and neuronal cells. Stem cells international 20120101
Triarylmethanes, a new class of cx50 inhibitors. Frontiers in pharmacology 20120101
The effect of antihistamines on seizures induced by increasing-current electroshocks: ketotifen, but not olopatadine, promotes the seizures in infant rats. Biological & pharmaceutical bulletin 20120101
Development of a highly sensitive methodology for quantitative determination of fexofenadine in a microdose study by multiple injection method using ultra-high performance liquid chromatography with tandem mass spectrometry. Biological & pharmaceutical bulletin 20120101
Comparison of nasal steroid with antihistamine in prophylactic treatment against pollinosis using an environmental challenge chamber. Allergy and asthma proceedings 20120101
Optimization using central composite design for antihistamines separation by nonaqueous capillary electrophoresis with electrochemical and electrochemiluminescence detections. The Analyst 20111221
Liquid extraction surface analysis mass spectrometry (LESA-MS) as a novel profiling tool for drug distribution and metabolism analysis: the terfenadine example. Rapid communications in mass spectrometry : RCM 20111215
Introduction of a modular automated voltage-clamp platform and its correlation with manual human Ether-à-go-go related gene voltage-clamp data. Assay and drug development technologies 20111201
Terfenadine induces apoptosis and autophagy in melanoma cells through ROS-dependent and -independent mechanisms. Apoptosis : an international journal on programmed cell death 20111201
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps). PLoS computational biology 20111201
Fexofenadine-induced urticaria. Annals of dermatology 20111201
Estimation of P-glycoprotein-mediated efflux in the oral absorption of P-gp substrate drugs from simultaneous analysis of drug dissolution and permeation. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20111120
Ameliorating effect of Yokukansan on the development of atopic dermatitis-like lesions and scratching behavior in socially isolated NC/Nga mice. Archives of dermatological research 20111101
Vectorial transport of fexofenadine across Caco-2 cells: involvement of apical uptake and basolateral efflux transporters. Molecular pharmaceutics 20111003
Evaluation of the genotoxicity and cytotoxicity of fexofenadine in cultured human peripheral blood lymphocytes. Toxicology in vitro : an international journal published in association with BIBRA 20111001
Simultaneous UFLC-ESI-MS/MS determination of piperine and piperlonguminine in rat plasma after oral administration of alkaloids from Piper longum L.: application to pharmacokinetic studies in rats. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20111001
Assessment of fexofenadine hydrochloride permeability and dissolution with an anionic surfactant using Caco-2 cells. Die Pharmazie 20111001
Validation of membrane vesicle-based breast cancer resistance protein and multidrug resistance protein 2 assays to assess drug transport and the potential for drug-drug interaction to support regulatory submissions. Xenobiotica; the fate of foreign compounds in biological systems 20110901
Physiologically based pharmacokinetic modeling of intestinal first-pass metabolism of CYP3A substrates with high intestinal extraction. Drug metabolism and disposition: the biological fate of chemicals 20110901
Estimating the risk of drug-induced proarrhythmia using human induced pluripotent stem cell-derived cardiomyocytes. Toxicological sciences : an official journal of the Society of Toxicology 20110901
Atypical antipsychotics and effects of muscarinic, serotonergic, dopaminergic and histaminergic receptor binding on insulin secretion in vivo: an animal model. Schizophrenia research 20110901
Quantification of the transporter substrate fexofenadine in cell lysates by liquid chromatography/tandem mass spectrometry. Rapid communications in mass spectrometry : RCM 20110830
Histaminergic modulation of acetylcholine-induced γ oscillations in rat hippocampus. Neuroreport 20110803
Block of the hERG channel by bupivacaine: Electrophysiological and modeling insights towards stereochemical optimization. European journal of medicinal chemistry 20110801
The biological basis and clinical significance of hormonal imprinting, an epigenetic process. Clinical epigenetics 20110801
Buspirone, fexofenadine, and omeprazole: quantification of probe drugs and their metabolites in human plasma. Journal of pharmaceutical and biomedical analysis 20110715
Simulation of multiple ion channel block provides improved early prediction of compounds' clinical torsadogenic risk. Cardiovascular research 20110701
Species differences in intestinal metabolic activities of cytochrome P450 isoforms between cynomolgus monkeys and humans. Drug metabolism and pharmacokinetics 20110601
In brief: fexofenadine (Allegra) and fruit juice. The Medical letter on drugs and therapeutics 20110530
Drug-induced QTC prolongation dangerously underestimates proarrhythmic potential: lessons from terfenadine. Journal of cardiovascular pharmacology 20110501
A new cytochrome P450 belonging to the 107L subfamily is responsible for the efficient hydroxylation of the drug terfenadine by Streptomyces platensis. Archives of biochemistry and biophysics 20110401
Transcriptional repression of the M channel subunit Kv7.2 in chronic nerve injury. Pain 20110401
Drug evaluation in cardiomyocytes derived from human induced pluripotent stem cells carrying a long QT syndrome type 2 mutation. European heart journal 20110401
Potent farnesyltransferase inhibitors with 1,4-diazepane scaffolds as novel destabilizing microtubule agents in hormone-resistant prostate cancer. Journal of medicinal chemistry 20110310
Analysis of Relationship between Levofloxacin and Corrected QT Prolongation Using a Clinical Data Warehouse. Healthcare informatics research 20110301
Poloxamer/cyclodextrin/chitosan-based thermoreversible gel for intranasal delivery of fexofenadine hydrochloride. Journal of pharmaceutical sciences 20110201
Roles of affinity and lipophilicity in the slow kinetics of prostanoid receptor antagonists on isolated smooth muscle preparations. British journal of pharmacology 20110201
Present state and future perspectives of using pluripotent stem cells in toxicology research. Archives of toxicology 20110201
The effects of the SLCO2B1 c.1457C > T polymorphism and apple juice on the pharmacokinetics of fexofenadine and midazolam in humans. Pharmacogenetics and genomics 20110201
Effect of histamine H1 receptor antagonists on TARC/CCL17 and MDC/CCL22 production from CD14+ cells induced by antigenic stimulation in vitro. International archives of allergy and immunology 20110101
Developmental changes in action potential prolongation by K+-channel blockers in chick myocardium. Journal of pharmacological sciences 20110101
The effect of histamine on ciliary beat frequency in the acute phase of allergic rhinitis. American journal of otolaryngology 20110101
Intranasal phototherapy is more effective than fexofenadine hydrochloride in the treatment of seasonal allergic rhinitis: results of a pilot study. Photochemistry and photobiology 20110101
Urticaria due to antihistamines. Journal of investigational allergology & clinical immunology 20110101
Validated stability-indicating spectrofluorimetric methods for the determination of ebastine in pharmaceutical preparations. Chemistry Central journal 20110101
A pseudo-randomised clinical trial of in situ gels of fluconazole for the treatment of oropharngeal candidiasis. Trials 20110101
Analysis of fexofenadine in pharmaceutical formulations using tris(1,10-phenanthroline)-ruthenium(II) peroxydisulphate chemiluminescence system in a multichip device. Luminescence : the journal of biological and chemical luminescence 20110101
Predicting drug side-effect profiles: a chemical fragment-based approach. BMC bioinformatics 20110101
hERGAPDbase: a database documenting hERG channel inhibitory potentials and APD-prolongation activities of chemical compounds. Database : the journal of biological databases and curation 20110101
A novel study design for antibiotic trials in acute exacerbations of COPD: MAESTRAL methodology. International journal of chronic obstructive pulmonary disease 20110101
Cardiac arrest provoked by itraconazole and amiodarone interaction: a case report. Journal of medical case reports 20110101
Development of a novel high-throughput analytical methodology, multiple injection method, for quantitative analysis in drug metabolism and pharmacokinetic studies using liquid chromatography with tandem mass spectrometry. Biological & pharmaceutical bulletin 20110101
Improvement of effect of water-in-oil microemulsion as an oral delivery system for fexofenadine: in vitro and in vivo studies. International journal of nanomedicine 20110101
IL-4 amplifies the pro-inflammatory effect of adenosine in human mast cells by changing expression levels of adenosine receptors. PloS one 20110101
Systematic review on the efficacy of fexofenadine in seasonal allergic rhinitis: a meta-analysis of randomized, double-blind, placebo-controlled clinical trials. International archives of allergy and immunology 20110101
Cough management: a practical approach. Cough (London, England) 20110101
Electrophysiological characterization of cardiomyocytes derived from human induced pluripotent stem cells. Journal of pharmacological sciences 20110101
Inhibition of HERG potassium channels by celecoxib and its mechanism. PloS one 20110101
Ebastine in chronic spontaneous urticaria in higher doses. Indian journal of dermatology 20110101
Substitute of Animals in Drug Research: An Approach Towards Fulfillment of 4R's. Indian journal of pharmaceutical sciences 20110101
Development of validated stability-indicating chromatographic method for the determination of fexofenadine hydrochloride and its related impurities in pharmaceutical tablets. Chemistry Central journal 20110101
In silico analysis of conformational changes induced by mutation of aromatic binding residues: consequences for drug binding in the hERG K+ channel. PloS one 20110101
Regional absorption of fexofenadine in rat intestine. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20101223
20(S)-ginsenoside Rh2 noncompetitively inhibits P-glycoprotein in vitro and in vivo: a case for herb-drug interactions. Drug metabolism and disposition: the biological fate of chemicals 20101201
A predictive ligand-based Bayesian model for human drug-induced liver injury. Drug metabolism and disposition: the biological fate of chemicals 20101201
CYP3A4*16 and CYP3A4*18 alleles found in East Asians exhibit differential catalytic activities for seven CYP3A4 substrate drugs. Drug metabolism and disposition: the biological fate of chemicals 20101201
Cytochrome P450-derived eicosanoids: the neglected pathway in cancer. Cancer metastasis reviews 20101201
Identification of human Ether-à-go-go related gene modulators by three screening platforms in an academic drug-discovery setting. Assay and drug development technologies 20101201
Monensin is a potent inducer of oxidative stress and inhibitor of androgen signaling leading to apoptosis in prostate cancer cells. Molecular cancer therapeutics 20101201
QTc interval prolongation by fexofenadine in healthy human volunteers and its correlation with plasma levels of fexofenadine: A demonstration of anticlockwise hysteresis. Indian journal of pharmacology 20101201
Development of a list of potentially inappropriate drugs for the korean elderly using the delphi method. Healthcare informatics research 20101201
Influence of drug-transporter polymorphisms on the pharmacokinetics of fexofenadine enantiomers. Xenobiotica; the fate of foreign compounds in biological systems 20101101
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis. Bioorganic & medicinal chemistry letters 20101101
Pharmacokinetics of fexofenadine following LPS administration to rats. Xenobiotica; the fate of foreign compounds in biological systems 20101101
Fruit juice inhibition of uptake transport: a new type of food-drug interaction. British journal of clinical pharmacology 20101101
H1-receptor antagonists terfenadine and loratadine inhibit spontaneous growth of neoplastic mast cells. Experimental hematology 20101001
The relationship between the drug concentration profiles in plasma and the drug doses in the colon. Chemical & pharmaceutical bulletin 20101001
Induction of inflammatory cell accumulation by TM-N49 and promutoxin, two novel phospholipase A(2). Toxicon : official journal of the International Society on Toxinology 20100915
Discovering drug-drug interactions: a text-mining and reasoning approach based on properties of drug metabolism. Bioinformatics (Oxford, England) 20100915
Efficacy of leukotriene antagonists as concomitant therapy in allergic rhinitis. The Laryngoscope 20100901
A quantitative structure-activity relationship for the modulation effects of flavonoids on p-glycoprotein-mediated transport. Chemical & pharmaceutical bulletin 20100901
Oral bepotastine: in allergic disorders. Drugs 20100820
Preparation and evaluation of fexofenadine microemulsions for intranasal delivery. International journal of pharmaceutics 20100816
Organic anion transporting polypeptide 1a/1b-knockout mice provide insights into hepatic handling of bilirubin, bile acids, and drugs. The Journal of clinical investigation 20100802
LuxR-dependent quorum sensing: computer aided discovery of new inhibitors structurally unrelated to N-acylhomoserine lactones. Bioorganic & medicinal chemistry letters 20100801
Effect of metronidazole on the pharmacokinetics of fexofenadine, a P-glycoprotein substrate, in healthy male volunteers. European journal of clinical pharmacology 20100701
Multivariate data analysis of factors affecting the in vitro dissolution rate and the apparent solubility for a model basic drug substance in aqueous media. Pharmaceutical research 20100701
[Normal tissue tolerance to external beam radiation therapy: esophagus]. Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique 20100701
Histamine and histamine receptor antagonists in cancer biology. Inflammation & allergy drug targets 20100701
Effects of K openers on the QT prolongation induced by HERG-blocking drugs in guinea-pigs. The Journal of pharmacy and pharmacology 20100701
Arrhythmic risk biomarkers for the assessment of drug cardiotoxicity: from experiments to computer simulations. Philosophical transactions. Series A, Mathematical, physical, and engineering sciences 20100628
Melt-in-mouth pellets of fexofenadine hydrochloride using crospovidone as an extrusion-spheronisation aid. AAPS PharmSciTech 20100601
Pharmacokinetics of fexofenadine: evaluation of a microdose and assessment of absolute oral bioavailability. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20100512
The effects of bilastine compared with cetirizine, fexofenadine, and placebo on allergen-induced nasal and ocular symptoms in patients exposed to aeroallergen in the Vienna Challenge Chamber. Inflammation research : official journal of the European Histamine Research Society ... [et al.] 20100501
Preparation and evaluation of spray-dried hyaluronic acid microspheres for intranasal delivery of fexofenadine hydrochloride. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20100416
Induction of microvascular leakage and histamine release by promutoxin, an Arg49 phospholipase A2. Toxicon : official journal of the International Society on Toxinology 20100401
Altered cytosolic Ca2+ dynamics in cultured Guinea pig cardiomyocytes as an in vitro model to identify potential cardiotoxicants. Toxicology in vitro : an international journal published in association with BIBRA 20100401
Interactions at human ether-à-go-go-related gene channels. Toxicological sciences : an official journal of the Society of Toxicology 20100401
Evaluation of in vivo P-glycoprotein phenotyping probes: a need for validation. Clinical pharmacokinetics 20100401
Direct analysis of dried blood spots utilizing desorption electrospray ionization (DESI) mass spectrometry. The Analyst 20100401
The pathophysiology, diagnosis and treatment of allergic rhinitis. Allergy, asthma & immunology research 20100401
Microdose study of a P-glycoprotein substrate, fexofenadine, using a non-radioisotope-labelled drug and LC/MS/MS. Journal of clinical pharmacy and therapeutics 20100401
Effect of piperine, a major component of black pepper, on the intestinal absorption of fexofenadine and its implication on food-drug interaction. Journal of food science 20100401
Measurement of fexofenadine concentration in micro-sample human plasma by a rapid and sensitive LC-MS/MS employing protein precipitation: application to a clinical pharmacokinetic study. Biomedical chromatography : BMC 20100301
Teriparatide is safe and effectively increases bone biomarkers in institutionalized individuals with osteoporosis. Journal of bone and mineral metabolism 20100301
Histamine influence on apoptosis in trophoblast cell cultures. Inflammation research : official journal of the European Histamine Research Society ... [et al.] 20100301
Toward a consensus model of the HERG potassium channel. ChemMedChem 20100301
Development of a novel system for estimating human intestinal absorption using Caco-2 cells in the absence of esterase activity. Drug metabolism and disposition: the biological fate of chemicals 20100201
Identification of novel substrates for human cytochrome P450 2J2. Drug metabolism and disposition: the biological fate of chemicals 20100201
Validation and application of a liquid chromatography-tandem mass spectrometric method for quantification of the drug transport probe fexofenadine in human plasma using 96-well filter plates. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20100201
Evaluation and performance of desorption electrospray ionization using a triple quadrupole mass spectrometer for quantitation of pharmaceuticals in plasma. Rapid communications in mass spectrometry : RCM 20100201
Building a tiered approach to in vitro predictive toxicity screening: a focus on assays with in vivo relevance. Combinatorial chemistry & high throughput screening 20100201
Loratadine versus levocetirizine in chronic idiopathic urticaria: A comparative study of efficacy and safety. Indian journal of pharmacology 20100201
Dog left ventricular midmyocardial myocytes for assessment of drug-induced delayed repolarization: short-term variability and proarrhythmic potential. British journal of pharmacology 20100101
Characterization of anti-inflammatory properties and evidence for no sedation liability for the novel antihistamine SUN-1334H. International archives of allergy and immunology 20100101
Update on the evaluation of a new drug for effects on cardiac repolarization in humans: issues in early drug development. British journal of pharmacology 20100101
Clinical pharmacokinetics of fexofenadine enantiomers. Expert opinion on drug metabolism & toxicology 20100101
Development of an in silico model for human skin permeation based on a Franz cell skin permeability assay. Bioorganic & medicinal chemistry letters 20100101
[Administration of premedication with fexofenadine for paclitaxel-induced hypersensitive reactions in breast cancer patients complicated with closed-angle glaucoma]. Gan to kagaku ryoho. Cancer & chemotherapy 20100101
The action potential and comparative pharmacology of stem cell-derived human cardiomyocytes. Journal of pharmacological and toxicological methods 20100101
Interferences of the autonomic nervous system with drug induced QT prolongation: a point to consider in non-clinical safety studies. Journal of pharmacological and toxicological methods 20100101
Uni- or bi-ventricular hypertrophy and susceptibility to drug-induced torsades de pointes. Journal of pharmacological and toxicological methods 20100101
Treatment of congestion in upper respiratory diseases. International journal of general medicine 20100101
Rhinitis in the geriatric population. Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology 20100101
Simultaneous determination of gliquidone, fexofenadine, buclizine, and levocetirizine in dosage formulation and human serum by RP-HPLC. Journal of chromatographic science 20100101
Preparation and evaluation of transdermal plasters containing norfloxacin: a novel treatment for burn wound healing. Eplasty 20100101
Reproducibility of the airway response to an exercise protocol standardized for intensity, duration, and inspired air conditions, in subjects with symptoms suggestive of asthma. Respiratory research 20100101
Azelastine hydrochloride, a dual-acting anti-inflammatory ophthalmic solution, for treatment of allergic conjunctivitis. Clinical ophthalmology (Auckland, N.Z.) 20100101
Emerging treatments in the management of schizophrenia - focus on sertindole. Drug design, development and therapy 20100101
Evaluation of terfenadine and ketoconazole-induced QT prolongation in conscious telemetered guinea pigs. Pharmacological reports : PR 20100101
Inhibitory effects of the methanol extract of Ganoderma lucidum on mosquito allergy-induced itch-associated responses in mice. Journal of pharmacological sciences 20100101
Fosaprepitant and aprepitant: an update of the evidence for their place in the prevention of chemotherapy-induced nausea and vomiting. Core evidence 20100101
Effects of anti-malarial drugs on the electrocardiographic QT interval modelled in the isolated perfused guinea pig heart system. Malaria journal 20100101
Development, clinical utility, and place in therapy of posaconazole for prevention and treatment of invasive fungal infections. Drug design, development and therapy 20100101
Stereoselective block of hERG channel by bupivacaine scrutinized at molecular level. Chimia 20100101
Study of the Complexation Behaviour of Fexofenadine with β-Cyclodextrin. Indian journal of pharmaceutical sciences 20100101
Clinical utility and patient adherence with ebastine for allergic rhinitis. Patient preference and adherence 20100101
Management of tinea capitis in childhood. Clinical, cosmetic and investigational dermatology 20100101
Update on the management of chronic eczema: new approaches and emerging treatment options. Clinical, cosmetic and investigational dermatology 20100101
Clinical safety and tolerability issues in use of triazole derivatives in management of fungal infections. Drug, healthcare and patient safety 20100101
Natural product taking its own place!!! Pharmacognosy research 20100101
Stereoselective Inhibition of the hERG1 Potassium Channel. Frontiers in pharmacology 20100101
Long-term treatment of patients with HIV-1: the role of atazanavir. HIV/AIDS (Auckland, N.Z.) 20100101
N-(3,4-dimethoxyphenethyl)-4-(6,7-dimethoxy-3,4-dihydroisoquinolin-2[1H]-yl)-6,7-dimethoxyquinazolin-2-amine (CP-100,356) as a 'chemical knock-out equivalent' to assess the impact of efflux transporters on oral drug absorption in the rat. Journal of pharmaceutical sciences 20091201
Leukotriene B(4) mediates sphingosylphosphorylcholine-induced itch-associated responses in mouse skin. The Journal of investigative dermatology 20091201
Genetic deficiency of carnitine/organic cation transporter 2 (slc22a5) is associated with altered tissue distribution of its substrate pyrilamine in mice. Biopharmaceutics & drug disposition 20091201
Effects of the P-glycoprotein inducer carbamazepine on fexofenadine pharmacokinetics. Therapeutic drug monitoring 20091201
Inhibition of the human ether-a-go-go-related gene (HERG) K+ channels by Lindera erythrocarpa. Journal of Korean medical science 20091201
Assessment of the antiobstructive effect of fexofenadine on nasal allergy challenge in patients with seasonal allergic rhinitis. Asian Pacific journal of allergy and immunology 20091201
A new homogeneous high-throughput screening assay for profiling compound activity on the human ether-a-go-go-related gene channel. Analytical biochemistry 20091101
Leukotriene receptor antagonist in the treatment of childhood allergic rhinitis--a randomized placebo-controlled study. Pediatric pulmonology 20091101
Efavirenz: a decade of clinical experience in the treatment of HIV. The Journal of antimicrobial chemotherapy 20091101
ESRD impairs nonrenal clearance of fexofenadine but not midazolam. Journal of the American Society of Nephrology : JASN 20091001
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum. Nature chemical biology 20091001
Comparing the stimulant effects of the H1-antagonist fexofenadine with 2 psychostimulants, modafinil and methylphenidate. Journal of clinical psychopharmacology 20091001
Allergen-induced airway inflammation and its therapeutic intervention. Allergy, asthma & immunology research 20091001
Unintended consequences of reducing QT-alert overload in a computerized physician order entry system. European journal of clinical pharmacology 20090901
Structural determinants for histamine H(1) affinity, hERG affinity and QTc prolongation in a series of terfenadine analogs. Bioorganic & medicinal chemistry letters 20090901
Effects of 4-Aminopyridine on Cloned hERG Channels Expressed in Mammalian Cells. Archives of drug information 20090901
Integration of preclinical and clinical data with pharmacokinetic modeling and simulation to evaluate fexofenadine as a probe for hepatobiliary transport function. Pharmaceutical research 20090801
Ureteral stones due to systemic mastocytosis: diagnostic and therapeutic characteristics. Urological research 20090801
Effect of St John's wort on the disposition of fexofenadine in the isolated perfused rat liver. The Journal of pharmacy and pharmacology 20090801
Iatrogenic QT Abnormalities and Fatal Arrhythmias: Mechanisms and Clinical Significance. Current cardiology reviews 20090801
Side chain flexibilities in the human ether-a-go-go related gene potassium channel (hERG) together with matched-pair binding studies suggest a new binding mode for channel blockers. Journal of medicinal chemistry 20090723
Fexofenadine: biochemical, pharmacokinetic and pharmacodynamic properties and its unique role in allergic disorders. Expert opinion on drug metabolism & toxicology 20090701
Allergies in India: a study on medication compliance. Journal of the Indian Medical Association 20090701
Pharmacokinetic drug interaction between fexofenadine and fluvastatin mediated by organic anion-transporting polypeptides in rats. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20090628
Ether-à-gogo-related gene (erg1) potassium channels shape the dark response of horizontal cells in the mammalian retina. Pflugers Archiv : European journal of physiology 20090601
Short-term effect of quercetin on the pharmacokinetics of fexofenadine, a substrate of P-glycoprotein, in healthy volunteers. European journal of clinical pharmacology 20090601
Selective inhibitors of CYP2J2 related to terfenadine exhibit strong activity against human cancers in vitro and in vivo. The Journal of pharmacology and experimental therapeutics 20090601
Ligand diversity of human and chimpanzee CYP3A4: activation of human CYP3A4 by lithocholic acid results from positive selection. Drug metabolism and disposition: the biological fate of chemicals 20090601
Ether-à-go-go-related gene K+ channels contribute to threshold excitability of mouse auditory brainstem neurons. The Journal of physiology 20090601
Effects of pranlukast hydrate on airway hyperresponsiveness in non-asthmatic patients with Japanese cedar pollinosis. Allergology international : official journal of the Japanese Society of Allergology 20090601
Fexofenadine hydrochloride enhances the efficacy of contact immunotherapy for extensive alopecia areata: Retrospective analysis of 121 cases. The Journal of dermatology 20090601
Suppression of histamine- and allergen-induced skin reactions: comparison of first- and second-generation antihistamines. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 20090601
Analogs of MK-499 are differentially affected by a mutation in the S6 domain of the hERG K+ channel. Biochemical pharmacology 20090515
Relationship between airborne pollen count and treatment outcome in Japanese cedar pollinosis patients. European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery 20090501
Managing toxicities and optimal dosing of targeted drugs in advanced kidney cancer. Current oncology (Toronto, Ont.) 20090501
A review of the efficacy of desloratadine, fexofenadine, and levocetirizine in the treatment of nasal congestion in patients with allergic rhinitis. Clinical therapeutics 20090501
Enantioselective disposition of fexofenadine with the P-glycoprotein inhibitor verapamil. British journal of clinical pharmacology 20090501
In vitro metabolism and inhibitory effects of pranlukast in human liver microsomes. Biological & pharmaceutical bulletin 20090401
Multiple H1-antihistamine-induced urticaria. The Journal of dermatology 20090401
Docking model of drug binding to the human ether-à-go-go potassium channel guided by tandem dimer mutant patch-clamp data: a synergic approach. Journal of medicinal chemistry 20090326
Safety of the novel atrial-selective K+-channel blocker AVE0118 in experimental heart failure. Naunyn-Schmiedeberg's archives of pharmacology 20090301
The inhibition of human multidrug and toxin extrusion 1 is involved in the drug-drug interaction caused by cimetidine. Drug metabolism and disposition: the biological fate of chemicals 20090301
Fexofenadine brain exposure and the influence of blood-brain barrier P-glycoprotein after fexofenadine and terfenadine administration. Drug metabolism and disposition: the biological fate of chemicals 20090301
Psychoactive medication and traffic safety. International journal of environmental research and public health 20090301
Calculation of QT shift in non clinical safety pharmacology studies. Journal of pharmacological and toxicological methods 20090101
Solar urticaria successfully treated with intravenous immunoglobulins. Dermatology (Basel, Switzerland) 20090101
Noninvasive technique for measurement of heartbeat regularity in zebrafish (Danio rerio) embryos. BMC biotechnology 20090101
IL-16 variability and modulation by antiallergic drugs in a murine experimental allergic rhinitis model. International archives of allergy and immunology 20090101
Influence of epinastine hydrochloride, an H1-receptor antagonist, on the function of mite allergen-pulsed murine bone marrow-derived dendritic cells in vitro and in vivo. Mediators of inflammation 20090101
Induction of mast cell accumulation, histamine release and skin edema by N49 phospholipase A2. BMC immunology 20090101
Validation of a voltage-sensitive dye (di-4-ANEPPS)-based method for assessing drug-induced delayed repolarisation in beagle dog left ventricular midmyocardial myocytes. Journal of pharmacological and toxicological methods 20090101
Role of atazanavir in the treatment of HIV infection. Therapeutics and clinical risk management 20090101
Fluticasone furoate nasal spray is more effective than fexofenadine for nighttime symptoms of seasonal allergy. Allergy and asthma proceedings 20090101
Evaluation of the efficacy and safety of olopatadine and fexofenadine compared with placebo in Japanese cedar pollinosis using an environmental exposure unit. Journal of investigational allergology & clinical immunology 20090101
Long-term effects of Panax ginseng on disposition of fexofenadine in rats in vivo. The American journal of Chinese medicine 20090101
Bioequivalence of fexofenadine tablet formulations assessed in healthy Iranian volunteers. Arzneimittel-Forschung 20090101
Engineering and validation of a novel lipid thin film for biomembrane modeling in lipophilicity determination of drugs and xenobiotics. Journal of biological engineering 20090101
Mechanistic modeling of hepatic transport from cells to whole body: application to napsagatran and fexofenadine. Molecular pharmaceutics 20090101
Drugs associated with more suicidal ideations are also associated with more suicide attempts. PloS one 20090101
Efficacy of repeated pretreatment with olopatadine hydrochloride on rhinitis induced by intranasal instillation of toluene-2,4-diisocyanate in rats. Pharmacology 20090101
Treatment of allergic rhinitis in infants and children: efficacy and safety of second-generation antihistamines and the leukotriene receptor antagonist montelukast. Drugs 20090101
Sudden elevation of liver enzymes in a 64-year-old patient: a case report. Cases journal 20090101
Treating rhinitis in the older population: special considerations. Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology 20090101
Chronic urticaria and treatment options. Indian journal of dermatology 20090101
Effects of fexofenadine on inflammatory mediators in nasal lavage fluid in intermittent allergic rhinitis. Journal of investigational allergology & clinical immunology 20090101
Contact urticaria: present scenario. Indian journal of dermatology 20090101
Management of difficult urticaria. Indian journal of dermatology 20090101
Psoriasis vulgaris and digestive system disorders: is there a linkage? Folia histochemica et cytobiologica 20090101
Update on terbinafine with a focus on dermatophytoses. Clinical, cosmetic and investigational dermatology 20090101
Ebastine in the light of CONGA recommendations for the development of third-generation antihistamines. Journal of asthma and allergy 20090101
QTc prolongation assessment in anticancer drug development: clinical and methodological issues. Ecancermedicalscience 20090101
Involvement of intestinal uptake transporters in the absorption of azithromycin and clarithromycin in the rat. Drug metabolism and disposition: the biological fate of chemicals 20081201
Design, data analysis, and simulation of in vitro drug transport kinetic experiments using a mechanistic in vitro model. Drug metabolism and disposition: the biological fate of chemicals 20081201
An ion channel library for drug discovery and safety screening on automated platforms. Assay and drug development technologies 20081201
Drug binding to the inactivated state is necessary but not sufficient for high-affinity binding to human ether-à-go-go-related gene channels. Molecular pharmacology 20081101
Narrowband ultraviolet B phototherapy is beneficial in antihistamine-resistant symptomatic dermographism: a pilot study. Journal of the American Academy of Dermatology 20081101
Potential benefit from an H1-receptor antagonist on postexercise syncope in the heat. Medicine and science in sports and exercise 20081101
Cyamemazine metabolites: effects on human cardiac ion channels in-vitro and on the QTc interval in guinea pigs. The Journal of pharmacy and pharmacology 20081101
Activation of proteinase-activated receptors induces itch-associated response through histamine-dependent and -independent pathways in mice. Journal of pharmacological sciences 20081101
Molecular determinants of hERG channel block by terfenadine and cisapride. Journal of pharmacological sciences 20081101
Validation of the use of nonnaive surgically catheterized rats for pharmacokinetics studies. Journal of the American Association for Laboratory Animal Science : JAALAS 20081101
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1. Journal of medicinal chemistry 20081009
Effectiveness of twice daily azelastine nasal spray in patients with seasonal allergic rhinitis. Therapeutics and clinical risk management 20081001
Mechanism of ritonavir changes in methadone pharmacokinetics and pharmacodynamics: II. Ritonavir effects on CYP3A and P-glycoprotein activities. Clinical pharmacology and therapeutics 20081001
Autonomic nervous system and cardiovascular system. Indian journal of pharmacology 20081001
Relative contribution of absorptive and secretory transporters to the intestinal absorption of fexofenadine in rats. International journal of pharmaceutics 20080901
Torsades de pointes liability inter-model comparisons: the experience of the QT PRODACT initiative. Pharmacology & therapeutics 20080801
Small mouse cholangiocytes proliferate in response to H1 histamine receptor stimulation by activation of the IP3/CaMK I/CREB pathway. American journal of physiology. Cell physiology 20080801
Probenecid, but not cystic fibrosis, alters the total and renal clearance of fexofenadine. Journal of clinical pharmacology 20080801
Literature-based evaluation of four 'hard endpoint' models for assessing drug-induced torsades de pointes liability. British journal of pharmacology 20080801
Fexofenadine effects on cognitive performance in aviators at ground level and simulated altitude. Aviation, space, and environmental medicine 20080801
Assessing QT prolongation in conscious dogs: validation of a beat-to-beat method. Pharmacology & therapeutics 20080801
The effects of topical (gel) astemizole and terfenadine on wound healing. Indian journal of pharmacology 20080801
A statistical methodology for drug-drug interaction surveillance. Statistics in medicine 20080720
A simple and rapid high performance liquid chromatographic method with fluorescence detection for the estimation of fexofenadine in rat plasma--application to preclinical pharmacokinetics. Talanta 20080715
Evaluation of the antihistamine effects of olopatadine, cetirizine and fexofenadine during a 24 h period: a double-blind, randomized, crossover, placebo-controlled comparison in skin responses induced by histamine iontophoresis. Archives of dermatological research 20080701
The effects of fexofenadine at steady-state on sleep architecture: a study using polysomnography in healthy Korean volunteers. Expert opinion on pharmacotherapy 20080701
Receptor-independent, vacuolar ATPase-mediated cellular uptake of histamine receptor-1 ligands: possible origin of pharmacological distortions and side effects. Toxicology and applied pharmacology 20080615
Spectrophotometric determination of terfenadine in pharmaceutical preparations by charge-transfer reactions. Talanta 20080615
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2). Journal of medicinal chemistry 20080612
Current industrial practices in assessing CYP450 enzyme induction: preclinical and clinical. The AAPS journal 20080601
Enzyme systems of detoxication - overview of recent approaches. Interdisciplinary toxicology 20080601
Identification of terfenadine as an inhibitor of human CD81-receptor HCV-E2 interaction: synthesis and structure optimization. Molecules (Basel, Switzerland) 20080507
Probing ligand binding modes of human cytochrome P450 2J2 by homology modeling, molecular dynamics simulation, and flexible molecular docking. Proteins 20080501
Involvement of multiple efflux transporters in hepatic disposition of fexofenadine. Molecular pharmacology 20080501
Practical recommendations on the use of lenalidomide in the management of myelodysplastic syndromes. Annals of hematology 20080501
Impact of basolateral multidrug resistance-associated protein (Mrp) 3 and Mrp4 on the hepatobiliary disposition of fexofenadine in perfused mouse livers. Drug metabolism and disposition: the biological fate of chemicals 20080501
The different effects of itraconazole on the pharmacokinetics of fexofenadine enantiomers. British journal of clinical pharmacology 20080501
Modest effect of impaired P-glycoprotein on the plasma concentrations of fexofenadine, quinidine, and loperamide following oral administration in collies. Drug metabolism and disposition: the biological fate of chemicals 20080501
Assessing QT prolongation in conscious dogs: validation of a beat-to-beat method. Pharmacology & therapeutics 20080501
Time-dependent inhibition of histamine-induced cutaneous responses by oral and intramuscular diphenhydramine and oral fexofenadine. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 20080501
Investigation of the inhibitory effects of various drugs on the hepatic uptake of fexofenadine in humans. Drug metabolism and disposition: the biological fate of chemicals 20080401
Analysis of disease-dependent sedative profiles of H(1)-antihistamines by large-scale surveillance using the visual analog scale. Methods and findings in experimental and clinical pharmacology 20080401
Prevention of chemotherapy-induced nausea and vomiting: focus on fosaprepitant. Therapeutics and clinical risk management 20080401
Terfenadine-induced apoptosis in human melanoma cells is mediated through Ca2+ homeostasis modulation and tyrosine kinase activity, independently of H1 histamine receptors. Carcinogenesis 20080301
Informatic tools and approaches in postmarketing pharmacovigilance used by FDA. The AAPS journal 20080301
Domoic acid toxicologic pathology: a review. Marine drugs 20080301
Deficient zebrafish ether-à-go-go-related gene channel gating causes short-QT syndrome in zebrafish reggae mutants. Circulation 20080219
Fexofenadine in pediatrics: oral tablet and suspension formulations. Expert opinion on pharmacotherapy 20080201
Effect of Ginkgo biloba extract on lopinavir, midazolam and fexofenadine pharmacokinetics in healthy subjects. Current medical research and opinion 20080201
A review of solifenacin in the treatment of urinary incontinence. Therapeutics and clinical risk management 20080201
Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model. Journal of medicinal chemistry 20080124
Isolation and structure elucidation of photodegradation products of fexofenadine. Journal of pharmaceutical and biomedical analysis 20080122
Development and validation of a rapid RP-HPLC method for the determination of cetirizine or fexofenadine with pseudoephedrine in binary pharmaceutical dosage forms. Journal of pharmaceutical and biomedical analysis 20080122
Aging-related changes of QT and RR intervals in conscious guinea pigs. Journal of pharmacological and toxicological methods 20080101
Multidrug resistance-associated protein 2 is primarily responsible for the biliary excretion of fexofenadine in mice. Drug metabolism and disposition: the biological fate of chemicals 20080101
Fexofenadine downmodulates antigen-presenting ability of murine epidermal Langerhans cells. Journal of dermatological science 20080101
Atopic cough-like cough hypersensitivity caused by active sensitization with protein fraction of Aspergillus restrictus strain A-17. Pulmonary pharmacology & therapeutics 20080101
Clinical pharmacokinetics and pharmacodynamics of desloratadine, fexofenadine and levocetirizine : a comparative review. Clinical pharmacokinetics 20080101
In vitro inhibition of rat basophilic leukaemia mast cell (RBL-2H3) degranulation by novel indane compounds. Inflammation research : official journal of the European Histamine Research Society ... [et al.] 20080101
Non-interventional study comparing treatment satisfaction in patients treated with antihistamines. Clinical drug investigation 20080101
An overview of harms associated with beta-lactam antimicrobials: where do the carbapenems fit in? Critical care (London, England) 20080101
Pharmacokinetics, safety and tolerability of an oral suspension of fexofenadine for children with allergic rhinitis. Allergy and asthma proceedings 20080101
Comparative efficacy of levocetirizine, desloratidine and fexofenadine by histamine wheal suppression test. Indian journal of dermatology, venereology and leprology 20080101
Loratadine provides early symptom control in seasonal allergic rhinitis. Allergy and asthma proceedings 20080101
Role of cytochrome P450 in drug interactions. Nutrition & metabolism 20080101
Extended driving impairs nocturnal driving performances. PloS one 20080101
A novel approach to the prediction of drug-drug interactions in humans based on the serum incubation method. Drug metabolism and pharmacokinetics 20080101
Visualization of first-pass drug metabolism of terfenadine by MALDI-imaging mass spectrometry. Drug metabolism letters 20080101
Psychological factors in asthma. Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology 20080101
Alternative and improved method for the simultaneous determination of fexofenadine and pseudoephedrine in their combined tablet formulation. Journal of pharmaceutical and biomedical analysis 20071221
Antihistamine and sodium cromoglycate medication for food cold water exercise-induced anaphylaxis. Allergy 20071201
[Linear dermatitis due to shiitake mushrooms]. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete 20071201
Two cases of alopecia areata responsive to fexofenadine. The Journal of dermatology 20071201
Safety and tolerability of fexofenadine hydrochloride, 15 and 30 mg, twice daily in children aged 6 months to 2 years with allergic rhinitis. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 20071201
Laser ablation electrospray ionization for atmospheric pressure, in vivo, and imaging mass spectrometry. Analytical chemistry 20071101
Fexofenadine/cyclodextrin inclusion complexation: phase solubility, thermodynamic, physicochemical, and computational analysis. Drug development and industrial pharmacy 20071101
Microdose clinical trial: quantitative determination of fexofenadine in human plasma using liquid chromatography/electrospray ionization tandem mass spectrometry. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20071015
Suppressive activity of fexofenadine hydrochloride on nitric oxide production in-vitro and in-vivo. The Journal of pharmacy and pharmacology 20071001
Safety and tolerability of fexofenadine for the treatment of allergic rhinitis in children 2 to 5 years old. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 20071001
Measurements of blood pressure and electrocardiogram in conscious freely moving guineapigs: a model for screening QT interval prolongation effects. Laboratory animals 20071001
Detection and reporting of drug-induced proarrhythmias: room for improvement. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 20070901
Possible involvement of 5-lipoxygenase metabolite in itch-associated response of mosquito allergy in mice. Journal of pharmacological sciences 20070901
QT prolongation and safety in the Indian population. Current drug safety 20070901
Selective, competitive and mechanism-based inhibitors of human cytochrome P450 2J2. Archives of biochemistry and biophysics 20070815
Inhibition of the HERG potassium channel by the tricyclic antidepressant doxepin. Biochemical pharmacology 20070801
State dependent dissociation of HERG channel inhibitors. British journal of pharmacology 20070801
Current assessment of risk-benefit by regulators: is it time to introduce decision analyses? Clinical pharmacology and therapeutics 20070801
Formaldehyde-induced urticarial vasculitis. The Australasian journal of dermatology 20070801
Phase II testing of sunitinib: the National Cancer Institute of Canada Clinical Trials Group IND Program Trials IND.182-185. Current oncology (Toronto, Ont.) 20070801
Role of posaconazole in the management of oropharyngeal and esophageal candidiasis. Therapeutics and clinical risk management 20070801
Combination therapy using fexofenadine, disodium cromoglycate, and a hypoallergenic amino acid-based formula induced remission in a patient with steroid-dependent, chronically active ulcerative colitis. International journal of colorectal disease 20070701
Histamine and spontaneously released mast cell granules affect the cell growth of human hepatocellular carcinoma cells. Experimental & molecular medicine 20070630
Pharmacological characterization of a chronic pruritus model induced by multiple application of 2,4,6-trinitrochlorobenzene in NC mice. European journal of pharmacology 20070601
Toxicological significance of mechanism-based inactivation of cytochrome p450 enzymes by drugs. Critical reviews in toxicology 20070601
Bioequivalence of two fexofenadine formulations in healthy human volunteers after single oral administration. Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia 20070601
A brief review of moxifloxacin in the treatment of elderly patients with community-acquired pneumonia (CAP). Clinical interventions in aging 20070601
Montelukast in the management of allergic rhinitis. Therapeutics and clinical risk management 20070601
Hydroxypropyl beta-cyclodextrins: a misleading vehicle for the in vitro hERG current assay. Journal of cardiovascular pharmacology 20070501
Characterization of antihistamine-human serum protein interactions by capillary electrophoresis. Journal of chromatography. A 20070420
Naringin is a major and selective clinical inhibitor of organic anion-transporting polypeptide 1A2 (OATP1A2) in grapefruit juice. Clinical pharmacology and therapeutics 20070401
Effect of oral ketoconazole on intestinal first-pass effect of midazolam and fexofenadine in cynomolgus monkeys. Drug metabolism and disposition: the biological fate of chemicals 20070301
Intestinal drug transporter expression and the impact of grapefruit juice in humans. Clinical pharmacology and therapeutics 20070301
Pharmacokinetics of fexofenadine enantiomers in healthy subjects. Chirality 20070301
Influences of histamine H1 receptor antagonists on maximal electroshock seizure in infant rats. Biological & pharmaceutical bulletin 20070301
Enhancing effect of surfactants on fexofenadine.HCl transport across the human nasal epithelial cell monolayer. International journal of pharmaceutics 20070207
Evaluation of cryopreserved human hepatocytes as an alternative in vitro system to microsomes for the prediction of metabolic clearance. Drug metabolism and disposition: the biological fate of chemicals 20070201
Assessment of the first and second generation antihistamines brain penetration and role of P-glycoprotein. Pharmaceutical research 20070201
Quantification of fexofenadine in human plasma by liquid chromatography coupled to electrospray tandem mass spectrometry using mosapride as internal standard. Biomedical chromatography : BMC 20070201
Simple and reliable HPLC analysis of fexofenadine hydrochloride in tablets and its application to dissolution studies. Die Pharmazie 20070201
The effect of fexofenadine hydrochloride on productivity and quality of life in patients with chronic idiopathic urticaria. Cutis 20070201
Determination of fexofenadine enantiomers in human plasma with high-performance liquid chromatography. Journal of pharmaceutical and biomedical analysis 20070117
A novel approach to data processing of the QT interval response in the conscious telemetered beagle dog. Journal of pharmacological and toxicological methods 20070101
Teriparatide in postmenopausal women with osteoporosis and mild or moderate renal impairment. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20070101
Differences in arrhythmogenicity between the canine right ventricular outflow tract and anteroinferior right ventricle in a model of Brugada syndrome. Heart rhythm 20070101
QT prolongation in guinea pigs for preliminary screening of torsadogenicity of drugs and drug-candidates. II. Journal of applied toxicology : JAT 20070101
Inhibition of cytokine-induced expression of T-cell cytokines by antihistamines. Journal of investigational allergology & clinical immunology 20070101
Synthesis and assessment of first-generation polyamidoamine dendrimer prodrugs to enhance the cellular permeability of P-gp substrates. Bioconjugate chemistry 20070101
Efficacy of fexofenadine versus desloratadine in suppressing histamine-induced wheal and flare. Allergy and asthma proceedings 20070101
Direct injection liquid chromatographic technique for simultaneous determination of two antihistaminic drugs and their main metabolites in serum. Journal of AOAC International 20070101
WJES and case reports/case series. World journal of emergency surgery : WJES 20070101
Evaluation of the guinea pig monophasic action potential (MAP) assay in predicting drug-induced delay of ventricular repolarisation using 12 clinically documented drugs. Journal of pharmacological and toxicological methods 20070101
Comparison of guinea-pig ventricular myocytes and dog Purkinje fibres for in vitro assessment of drug-induced delayed repolarization. Journal of pharmacological and toxicological methods 20070101
Comparison of the QT interval response during sinus and paced rhythm in conscious and anesthetized beagle dogs. Journal of pharmacological and toxicological methods 20070101
Some pharmacokinetic aspects of the lipophilic terfenadine and zwitterionic fexofenadine in humans. Drugs in R&D 20070101
Medicinal importance of grapefruit juice and its interaction with various drugs. Nutrition journal 20070101
Improved functional expression of recombinant human ether-a-go-go (hERG) K+ channels by cultivation at reduced temperature. BMC biotechnology 20070101
Food-dependent exercise-induced anaphylaxis: a case related to chickpea ingestion and review. Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology 20070101
Aprepitant: the evidence for its place in the prevention of chemotherapy-induced nausea and vomiting. Core evidence 20070101
The proarrhythmic antihistaminic drug terfenadine increases spontaneous calcium release in human atrial myocytes. European journal of pharmacology 20061228
Electrophysiological effects of brompheniramine on cardiac ion channels and action potential. Pharmacological research 20061201
Comparison of four rate-correction algorithms for the ventricular repolarization period in assessing net effects of IKr blockers in dogs. Journal of pharmacological sciences 20061201
Long QT syndrome in a patient with allergic rhinoconjunctivitis and auto-immune diabetes: focus on the choice of anti-H1 drugs. European annals of allergy and clinical immunology 20061201
The CML-related oncoprotein BCR/ABL induces expression of histidine decarboxylase (HDC) and the synthesis of histamine in leukemic cells. Blood 20061115
Lack of dose-dependent effects of itraconazole on the pharmacokinetic interaction with fexofenadine. Drug metabolism and disposition: the biological fate of chemicals 20061101
Inhibitory effect of carboxylic acid group on hERG binding. Bioorganic & medicinal chemistry letters 20061101
Treatment of allergic rhinitis can improve blood pressure control. Journal of human hypertension 20061101
Altering extracellular potassium concentration does not modulate drug block of human ether-a-go-go-related gene (hERG) channels. Clinical and experimental pharmacology & physiology 20061101
New antihistamines: a critical view. Jornal de pediatria 20061101
Ultrarush venom desensitization after systemic reactions during conventional venom immunotherapy. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 20061101
[Inhibition of histamine-induced wheel after a recommended single dose administration of 10 mg cetirizine, 5 mg desloratadine, 120 i 180 mg fexofenadine, 5 mg levocetirizine and 10 mg loratadine--a randomized, double-blind, placebo controlled trial]. Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego 20061101
[The effect of 5-days of cetirizine, desloratadine, fexofenadine 120 and 180 mg, levocetirizine, loratadine treatment on the histamine-induced skin reaction and skin blood flow--a randomized, double-blind, placebo controlled trial]. Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego 20061101
Involvement of ionotropic purinergic receptors in the histamine-induced enhancement of the cough reflex sensitivity in guinea pigs. European journal of pharmacology 20061010
QT interval prolongation and beyond. Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc 20061001
Onset of action of fexofenadine hydrochloride 60 mg/pseudoephedrine hydrochloride 120 mg in subjects aged 12 years with moderate to severe seasonal allergic rhinitis: a pooled analysis of two single-dose, randomized, double-blind, placebo-controlled allergen exposure unit studies. Clinical therapeutics 20061001
H1 histamine receptor antagonists induce genotoxic and caspase-2-dependent apoptosis in human melanoma cells. Carcinogenesis 20060901
Effects of single and multiple doses of itraconazole on the pharmacokinetics of fexofenadine, a substrate of P-glycoprotein. British journal of clinical pharmacology 20060901
Altered oral bioavailability and pharmacokinetics of P-glycoprotein substrates by coadministration of biochanin A. Journal of pharmaceutical sciences 20060901
Long QT 1 mutation KCNQ1A344V increases local anesthetic sensitivity of the slowly activating delayed rectifier potassium current. Anesthesiology 20060901
Hepatobiliary disposition of a drug/metabolite pair: Comprehensive pharmacokinetic modeling in sandwich-cultured rat hepatocytes. The Journal of pharmacology and experimental therapeutics 20060801
Facial thermography is a sensitive tool to determine antihistaminic activity: comparison of levocetirizine and fexofenadine. British journal of clinical pharmacology 20060801
Alteration of fexofenadine disposition in the rat isolated perfused liver following injection of bacterial lipopolysaccharide. Clinical and experimental pharmacology & physiology 20060801
Transporter-mediated intestinal absorption of fexofenadine in rats. Drug metabolism and pharmacokinetics 20060801
A combined neurophysiological and behavioural study into the stimulating effects of fexofenadine on performance. Journal of psychopharmacology (Oxford, England) 20060701
In vivo recording of adult zebrafish electrocardiogram and assessment of drug-induced QT prolongation. American journal of physiology. Heart and circulatory physiology 20060701
First-pass effects of verapamil on the intestinal absorption and liver disposition of fexofenadine in the porcine model. Drug metabolism and disposition: the biological fate of chemicals 20060701
Stimulating effects of the antihistamine fexofenadine: testing the dopamine transporter hypothesis. Psychopharmacology 20060701
Time-dependent interaction between lopinavir/ritonavir and fexofenadine. Journal of clinical pharmacology 20060701
Allergy medication in Japanese volunteers: treatment effect of single doses on nocturnal sleep architecture and next day residual effects. Current medical research and opinion 20060701
Application of a mathematical topological pattern of antihistaminic activity for the selection of new drug candidates and pharmacology assays. Journal of medicinal chemistry 20060615
Differences of promethazine and terfenadine on ion channels in guinea pig ventricular myocytes. Chinese medical journal 20060605
Efficacy and central nervous system impairment of newer-generation prescription antihistamines in seasonal allergic rhinitis. Southern medical journal 20060601
Voriconazole in the management of nosocomial invasive fungal infections. Therapeutics and clinical risk management 20060601
Cellular basis for trigger and maintenance of ventricular fibrillation in the Brugada syndrome model: high-resolution optical mapping study. Journal of the American College of Cardiology 20060516
Design and synthesis of selective, high-affinity inhibitors of human cytochrome P450 2J2. Bioorganic & medicinal chemistry letters 20060515
New insights about HERG blockade obtained from protein modeling, potential energy mapping, and docking studies. Bioorganic & medicinal chemistry 20060501
Inhibition of oat3-mediated renal uptake as a mechanism for drug-drug interaction between fexofenadine and probenecid. Drug metabolism and disposition: the biological fate of chemicals 20060501
Effect of P-glycoprotein on intestinal absorption and brain penetration of antiallergic agent bepotastine besilate. Drug metabolism and disposition: the biological fate of chemicals 20060501
Microsphere-based protease assays and screening application for lethal factor and factor Xa. Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501
Once-daily immediate-release fexofenadine and sustained-release pseudoephedrine combination: a new treatment option for allergic rhinitis. Expert opinion on pharmacotherapy 20060501
Effects of itraconazole and diltiazem on the pharmacokinetics of fexofenadine, a substrate of P-glycoprotein. British journal of clinical pharmacology 20060501
Pustular exacerbation of psoriasis due to fexofenadine. Clinical and experimental dermatology 20060501
Fexofenadine in horses: pharmacokinetics, pharmacodynamics and effect of ivermectin pretreatment. Journal of veterinary pharmacology and therapeutics 20060401
Effect of pretreatment with fexofenadine on the safety of immunotherapy in patients with allergic rhinitis. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 20060401
Dimethyl lithospermate B, an extract of Danshen, suppresses arrhythmogenesis associated with the Brugada syndrome. Circulation 20060321
Glutathione and thiolated chitosan inhibit multidrug resistance P-glycoprotein activity in excised small intestine. Journal of controlled release : official journal of the Controlled Release Society 20060310
Comparative evaluation of HERG currents and QT intervals following challenge with suspected torsadogenic and nontorsadogenic drugs. The Journal of pharmacology and experimental therapeutics 20060301
Long-term bradycardia caused by atrioventricular block can remodel the canine heart to detect the histamine H1 blocker terfenadine-induced torsades de pointes arrhythmias. British journal of pharmacology 20060301
The effect of short- and long-term administration of verapamil on the disposition of cytochrome P450 3A and P-glycoprotein substrates. Clinical pharmacology and therapeutics 20060301
[Extension of QT interval as a consequence of risk factor accumulation--case study]. Vnitrni lekarstvi 20060301
Effects of cyamemazine on hERG, INa, ICa, Ito, Isus and IK1 channel currents, and on the QTc interval in guinea pigs. European journal of pharmacology 20060227
Analysis of pharmaceutical preparations containing antihistamine drugs by micellar liquid chromatography. Journal of pharmaceutical and biomedical analysis 20060213
Efficacy of fexofenadine in the prophylactic control of cat allergen-induced allergic rhinitis. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 20060201
Effect of erythromycin on the absorption of fexofenadine in the jejunum, ileum and colon determined using local intubation in healthy volunteers. International journal of clinical pharmacology and therapeutics 20060201
Fexofenadine, an H1-receptor antagonist, partially but rapidly inhibits the itch of contact dermatitis induced by diphenylcyclopropenone in patients with alopecia areata. The Journal of dermatology 20060201
Potent pruritogenic action of tryptase mediated by PAR-2 receptor and its involvement in anti-pruritic effect of nafamostat mesilate in mice. European journal of pharmacology 20060113
Differential effects of fexofenadine on arachidonic acid metabolism in cultured human monocytes. Pharmacology 20060101
Long QT syndrome: reduced repolarization reserve and the genetic link. Journal of internal medicine 20060101
A novel predictive pharmacokinetic/pharmacodynamic model of repolarization prolongation derived from the effects of terfenadine, cisapride and E-4031 in the conscious chronic av node--ablated, His bundle-paced dog. Journal of pharmacological and toxicological methods 20060101
[Long QT interval. Interaction of terfenadine and itraconazole]. Medizinische Monatsschrift fur Pharmazeuten 20060101
Drug-induced QT prolongation: an update. Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc 20060101
Enzymatic characteristics of CYP3A5 and CYP3A4: a comparison of in vitro kinetic and drug-drug interaction patterns. Xenobiotica; the fate of foreign compounds in biological systems 20060101
Dimethyl sulfoxide effects on hERG channels expressed in HEK293 cells. Journal of pharmacological and toxicological methods 20060101
In vivo pharmacological characterisation of bilastine, a potent and selective histamine H1 receptor antagonist. Drugs in R&D 20060101
Dyspnea assessment and adverse events during sputum induction in COPD. BMC pulmonary medicine 20060101
Stimulating effects of H1-antagonists. Current pharmaceutical design 20060101
Efficacy of desloratadine, 5 mg, compared with fexofenadine, 180 mg, in patients with symptomatic seasonal allergic rhinitis. Allergy and asthma proceedings 20060101
Saliva secretion in patients with allergic rhinitis. International archives of allergy and immunology 20060101
Marketing of a new non-sedating antihistamine (fexofenadine) puts an additional burden on healthcare system resources in Israel. The European journal of general practice 20060101
Simultaneous quantification of fexofenadine and pseudoephedrine in human plasma by liquid chromatography/tandem mass spectrometry with electrospray ionization: method development, validation and application to a clinical study. Rapid communications in mass spectrometry : RCM 20060101
New evidence of H1-receptor independent COX-2 inhibition by fexofenadine HCl in vitro. Pharmacology 20060101
The effect of fexofenadine on pruritus in a mouse model (HR-ADf) of atopic dermatitis. The Journal of international medical research 20060101
Selecting the optimal oral antihistamine for patients with allergic rhinitis. Drugs 20060101
[Safety of venom immunotherapy in patients pretreated with antihistamines--a retrospective study]. Pneumonologia i alergologia polska 20060101
[Treatment of allergic rhinitis associated with hypothyroidism]. Vestnik otorinolaringologii 20060101
The methanol disolvate and the dihydrate of fexofenadine, an antihistamine drug. Acta crystallographica. Section C, Crystal structure communications 20051201
Localized periorbital edema induced by Ibuprofen. The Journal of dermatology 20051201
The efficacy and safety of 30 mg fexofenadine HCl bid in pediatric patients with allergic rhinitis. Asian Pacific journal of allergy and immunology 20051201
Safety and tolerability of oral antifungal agents in the treatment of fungal nail disease: a proven reality. Therapeutics and clinical risk management 20051201
Drug-induced proarrhythmia and use of QTc-prolonging agents: clues for clinicians. Heart rhythm 20051101
hERG1 channels are overexpressed in glioblastoma multiforme and modulate VEGF secretion in glioblastoma cell lines. British journal of cancer 20051003
Contribution of OATP (organic anion-transporting polypeptide) family transporters to the hepatic uptake of fexofenadine in humans. Drug metabolism and disposition: the biological fate of chemicals 20051001
Effects of fexofenadine hydrochloride in a guinea pig model of antigen-induced rhinitis. Pharmacology 20051001
Reduction of repolarization reserve by halothane anaesthesia sensitizes the guinea-pig heart for drug-induced QT interval prolongation. British journal of pharmacology 20051001
Effects of fexofenadine and hydroxyzine on brake reaction time during car-driving with cellular phone use. Human psychopharmacology 20051001
Transport of anti-allergic drugs across the passage cultured human nasal epithelial cell monolayer. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20051001
Brugada syndrome and ischemia-induced ST-segment elevation. Similarities and differences. Journal of electrocardiology 20051001
Treatment of ear pain in pilots in flight. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 20051001
The various effects of four H1-antagonists on serum substance P levels in patients with atopic dermatitis. The Journal of dermatology 20051001
Grape fruit juice-drug interactions. Pakistan journal of pharmaceutical sciences 20051001
[Wheat anaphylaxis enhanced by administration of acetylsalicylic acid or by exercise]. Arerugi = [Allergy] 20051001
Modeling K(m) values using electrotopological state: substrates for cytochrome P450 3A4-mediated metabolism. Bioorganic & medicinal chemistry letters 20050915
L-selectin expression on neutrophils from allergic patients. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 20050901
Suppression of the histamine-induced wheal and flare response by fexofenadine HCl 60 mg twice daily, loratadine 10 mg once daily and placebo in healthy Japanese volunteers. Current medical research and opinion 20050901
Addition of fexofenadine to inhaled corticosteroid therapy to reduce inflammatory biomarkers in atopic asthma. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 20050901
Determination of fexofenadine in tablets by capillary electrophoresis in free solution and in solution with cyclodextrins as analyte carriers. Drug development and industrial pharmacy 20050901
Histamine H1 receptor occupancy and pharmacodynamics of second generation H1-antihistamines. Inflammation research : official journal of the European Histamine Research Society ... [et al.] 20050901
Suppression of matrix metalloproteinase production in nasal fibroblasts by tranilast, an antiallergic agent, in vitro. Mediators of inflammation 20050814
Development and validation of dissolution tests for fexofenadine hydrochloride capsules and coated tablets. Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques 20050811
Management of seasonal allergic rhinitis: comparative efficacy of the newer-generation prescription antihistamines. Journal of the American Academy of Nurse Practitioners 20050801
Effect of itraconazole on the pharmacokinetics and pharmacodynamics of fexofenadine in relation to the MDR1 genetic polymorphism. Clinical pharmacology and therapeutics 20050801
The advantages of the Ussing chamber in drug absorption studies. Journal of biomolecular screening 20050801
Assessing the therapeutic benefits of antihistamines for the treatment of chronic idiopathic urticaria--a requirement for well-designed comparative clinical studies. The Journal of dermatological treatment 20050801
Practical application of guinea pig telemetry system for QT evaluation. The Journal of toxicological sciences 20050801
P-glycoprotein plays a major role in the efflux of fexofenadine in the small intestine and blood-brain barrier, but only a limited role in its biliary excretion. Drug metabolism and disposition: the biological fate of chemicals 20050701
Levocetirizine has a longer duration of action on improving total nasal symptoms score than fexofenadine after single administration. British journal of clinical pharmacology 20050701
Take allergy drug and sniff flowers safely? Consumer reports 20050601
Once-daily fexofenadine treatment for chronic idiopathic urticaria: a multicenter, randomized, double-blind, placebo-controlled study. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 20050601
Calculating virtual log P in the alkane/water system (log P(N)(alk)) and its derived parameters deltalog P(N)(oct-alk) and log D(pH)(alk). Journal of medicinal chemistry 20050505
Osteoporosis, teriparatide, and dosing of calcium and vitamin D. The New England journal of medicine 20050505
Fexofenadine pharmacokinetics are associated with a polymorphism of the SLCO1B1 gene (encoding OATP1B1). British journal of clinical pharmacology 20050501
QT interval prolongation and torsades de pointes due to a coadministration of metronidazole and amiodarone. Pacing and clinical electrophysiology : PACE 20050501
Single-dose and steady-state bioequivalence of fexofenadine and pseudoephedrine combination tablets compared with individual formulations in healthy adults. Current medical research and opinion 20050501
A pharmacophore hypothesis for P-glycoprotein substrate recognition using GRIND-based 3D-QSAR. Journal of medicinal chemistry 20050421
Preferential downmodulation of certain chemokines by fexofenadine in human keratinocytes. Journal of dermatological science 20050401
The efficacy of short-term administration of 3 antihistamines vs placebo under natural exposure to Japanese cedar pollen. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 20050401
Effect of trazodone on hERG channel current and QT-interval. European journal of pharmacology 20050307
H1 receptor-mediated vasodilatation contributes to postexercise hypotension. The Journal of physiology 20050301
CYP3A and P-glycoprotein activity induction with St. John's Wort in healthy volunteers from 6 ethnic populations. Journal of clinical pharmacology 20050301
Effect of grapefruit juice volume on the reduction of fexofenadine bioavailability: possible role of organic anion transporting polypeptides. Clinical pharmacology and therapeutics 20050301
Inhibition of tryptase release from human colon mast cells by histamine receptor antagonists. Asian Pacific journal of allergy and immunology 20050301
Clinical outcomes and management of mechanism-based inhibition of cytochrome P450 3A4. Therapeutics and clinical risk management 20050301
Effect of fruit juices on the oral bioavailability of fexofenadine in rats. Journal of pharmaceutical sciences 20050201
Fexofenadine improves the quality of life and work productivity in Japanese patients with seasonal allergic rhinitis during the peak cedar pollinosis season. International archives of allergy and immunology 20050201
Identification of human P450 isoforms involved in the metabolism of the antiallergic drug, oxatomide, and its kinetic parameters and inhibition constants. Biological & pharmaceutical bulletin 20050201
[Torsades de pointes caused by cetirizine overdose]. Archives des maladies du coeur et des vaisseaux 20050201
Evaluation of first-pass cytochrome P4503A (CYP3A) and P-glycoprotein activities using alfentanil and fexofenadine in combination. Journal of clinical pharmacology 20050101
Different effects of three transporting inhibitors, verapamil, cimetidine, and probenecid, on fexofenadine pharmacokinetics. Clinical pharmacology and therapeutics 20050101
Mechanism-based inhibition of cytochrome P450 3A4 by therapeutic drugs. Clinical pharmacokinetics 20050101
Minimal important difference (MID) of the Dermatology Life Quality Index (DLQI): results from patients with chronic idiopathic urticaria. Health and quality of life outcomes 20050101
Use of a five-channel multiplexed electrospray quadrupole time-of-flight hybrid mass spectrometer for metabolite identification. Rapid communications in mass spectrometry : RCM 20050101
Estimation of potency of HERG channel blockers: impact of voltage protocol and temperature. Journal of pharmacological and toxicological methods 20050101
Cardiovascular parameters in anaesthetized guinea pigs: a safety pharmacology screening model. Journal of pharmacological and toxicological methods 20050101
Structural determinants for high-affinity block of hERG potassium channels. Novartis Foundation symposium 20050101
In vivo antimuscarinic actions of the third generation antihistaminergic agent, desloratadine. BMC pharmacology 20050101
Comparative effects of fexofenadine and montelukast on allergen-induced wheal and flare. Allergy and asthma proceedings 20050101
Capillary electrophoresis method for fexofenadine hydrochloride in capsules. Journal of AOAC International 20050101
Comparative efficacy of cetirizine and fexofenadine for seasonal allergic rhinitis, 5-12 hours postdose, in the environmental exposure unit. Allergy and asthma proceedings 20050101
The effect of fexofenadine on expression of intercellular adhesion molecule 1 and induction of apoptosis on peripheral eosinophils. Allergy and asthma proceedings 20050101
A Chronic Fatigue Syndrome - related proteome in human cerebrospinal fluid. BMC neurology 20050101
Greater risk of incident asthma cases in adults with allergic rhinitis and effect of allergen immunotherapy: a retrospective cohort study. Respiratory research 20050101
QT PRODACT: a multi-site study of in vitro action potential assays on 21 compounds in isolated guinea-pig papillary muscles. Journal of pharmacological sciences 20050101
QT PRODACT: in vivo QT assay in the conscious dog for assessing the potential for QT interval prolongation by human pharmaceuticals. Journal of pharmacological sciences 20050101
QT PRODACT: in vivo QT assay with a conscious monkey for assessment of the potential for drug-induced QT interval prolongation. Journal of pharmacological sciences 20050101
QT PRODACT: sensitivity and specificity of the canine telemetry assay for detecting drug-induced QT interval prolongation. Journal of pharmacological sciences 20050101
Simultaneous determination of ebastine and its three metabolites in plasma using liquid chromatography-tandem mass spectrometry. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20041225
Evidence of significant contribution from CYP3A5 to hepatic drug metabolism. Drug metabolism and disposition: the biological fate of chemicals 20041201
The utility of mixed-effects covariate analysis in rapid selection of doses in pediatric subjects: a case study with fexofenadine hydrochloride. Biopharmaceutics & drug disposition 20041201
Similar rapid onset of action and magnitude of effect of fexofenadine and cetirizine as assessed by inhibition of histamine-induced wheal-and-flare reaction. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 20041201
Suppressive activity of fexofenadine hydrochloride on metalloproteinase production from nasal fibroblasts in vitro. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 20041201
Microbial oxidation of terfenadine and ebastine into fexofenadine and carebastine. Bioorganic & medicinal chemistry letters 20041101
A variant 2677A allele of the MDR1 gene affects fexofenadine disposition. Clinical pharmacology and therapeutics 20041101
Comparative pharmacology of guinea pig cardiac myocyte and cloned hERG (I(Kr)) channel. Journal of cardiovascular electrophysiology 20041101
The crystallisation of a model hydrophobic drug (terfenadine) following exposure to humidity and organic vapours. International journal of pharmaceutics 20041013
Comparison of alamar blue and MTT assays for high through-put screening. Toxicology in vitro : an international journal published in association with BIBRA 20041001
Steady-state brain concentrations of antihistamines in rats: interplay of membrane permeability, P-glycoprotein efflux and plasma protein binding. Pharmacology 20041001
Automated tight seal electrophysiology for assessing the potential hERG liability of pharmaceutical compounds. Assay and drug development technologies 20041001
Effects of bepotastine, cetirizine, fexofenadine, and olopatadine on histamine-induced wheal-and flare-response, sedation, and psychomotor performance. Clinical and experimental dermatology 20040901
Drug-drug interactions of Z-338, a novel gastroprokinetic agent, with terfenadine, comparison with cisapride, and involvement of UGT1A9 and 1A8 in the human metabolism of Z-338. European journal of pharmacology 20040823
Terfenadine induces thymocyte apoptosis via mitochondrial pathway. European journal of pharmacology 20040802
Venom immunotherapy: adverse reactions and treatment failure. Current opinion in allergy and clinical immunology 20040801
Central effects of fexofenadine and cetirizine: measurement of psychomotor performance, subjective sleepiness, and brain histamine H1-receptor occupancy using 11C-doxepin positron emission tomography. Journal of clinical pharmacology 20040801
Comparison of pharmacokinetics and metabolism of desloratadine, fexofenadine, levocetirizine and mizolastine in humans. Fundamental & clinical pharmacology 20040801
Validation of the Dermatology Life Quality Index as an outcome measure for urticaria-related quality of life. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 20040801
Efficacy of azelastine nasal spray in seasonal allergic rhinitis patients who remain symptomatic after treatment with fexofenadine. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 20040801
A novel membrane sensor for histamine H1-receptor antagonist 'fexofenadine'. Analytical sciences : the international journal of the Japan Society for Analytical Chemistry 20040801
Transport characteristics of fexofenadine in the Caco-2 cell model. Pharmaceutical research 20040801
Intradermal nociceptin elicits itch-associated responses through leukotriene B(4) in mice. The Journal of investigative dermatology 20040701
Validation of a [3H]astemizole binding assay in HEK293 cells expressing HERG K+ channels. Journal of pharmacological sciences 20040701
Role of sodium and calcium channel block in unmasking the Brugada syndrome. Heart rhythm 20040701
Determination of fexofenadine in human plasma using 96-well solid phase extraction and HPLC with tandem mass spectrometric detection. Journal of pharmaceutical and biomedical analysis 20040629
Liquid chromatographic determination of fexofenadine in human plasma with fluorescence detection. Journal of pharmaceutical and biomedical analysis 20040629
Drugs, hERG and sudden death. Cell calcium 20040601
Effects of single or combined histamine H1-receptor and leukotriene CysLT1-receptor antagonism on nasal adenosine monophosphate challenge in persistent allergic rhinitis. British journal of clinical pharmacology 20040601
Lead identification for modulators of multidrug resistance based on in silico screening with a pharmacophoric feature model. Archiv der Pharmazie 20040601
Safety and efficacy of oral fexofenadine in children with seasonal allergic rhinitis--a pooled analysis of three studies. Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology 20040601
Involvement of histamine H4 and H1 receptors in scratching induced by histamine receptor agonists in Balb C mice. British journal of pharmacology 20040501
Molecular determinants for high-affinity block of human EAG potassium channels by antiarrhythmic agents. Molecular pharmacology 20040501
Fexofenadine does not affect omeprazole pharmacokinetics: both are putative P-glycoprotein substrates. Basic & clinical pharmacology & toxicology 20040501
Inactivation gating determines drug potency: a common mechanism for drug blockade of HERG channels. Acta pharmacologica Sinica 20040501
Acid-base cosolvent method for determining aqueous permeability of amiodarone, itraconazole, tamoxifen, terfenadine and other very insoluble molecules. Chemical & pharmaceutical bulletin 20040501
Identification of human p450 isoforms involved in the metabolism of the antiallergic drug, oxatomide, and its inhibitory effect on enzyme activity. Biological & pharmaceutical bulletin 20040501
Comparative efficacy of wheal-and-flare suppression among various non-sedating antihistamines and the pharmacologic insights to their efficacy. Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20040501
Integrating in vitro kinetic data from compounds exhibiting induction, reversible inhibition and mechanism-based inactivation: in vitro study design. Current drug metabolism 20040401
Repeated dosing effects of mediator antagonists in inhaled corticosteroid-treated atopic asthmatic patients. Chest 20040401
A placebo-controlled evaluation of butterbur and fexofenadine on objective and subjective outcomes in perennial allergic rhinitis. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 20040401
Comparative effects of desloratadine, fexofenadine, and levocetirizine on nasal adenosine monophosphate challenge in patients with perennial allergic rhinitis. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 20040401
Lack of association between fexofenadine and rhabdomyolysis. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20040401
Mizolastine and fexofenadine modulate cytokine pattern after nasal allergen challenge. European annals of allergy and clinical immunology 20040401
Physicochemical features of the HERG channel drug binding site. The Journal of biological chemistry 20040312
Suppressive activity of fexofenadine hydrochloride on thymus- and activation-regulated chemokine production from human peripheral blood leukocytes in response to antigenic stimulation in vitro. International archives of allergy and immunology 20040301
The effects of fexofenadine on eosinophilia and systemic anaphylaxis in mice infected with Trichinella spiralis. International immunopharmacology 20040301
Antihistamines and driving ability: evidence from on-the-road driving studies during normal traffic. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 20040301
Polymorphism in generic drug product development. Advanced drug delivery reviews 20040223
Differential effect of HERG blocking agents on cardiac electrical alternans in the guinea pig. European journal of pharmacology 20040220
Application of data mining techniques in pharmacovigilance. British journal of clinical pharmacology 20040201
The effects of butterbur on the histamine and allergen cutaneous response. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 20040201
Assessing patient satisfaction with desloratadine after conversion from loratadine, fexofenadine, or cetirizine. Managed care interface 20040201
Lack of action potential-prolonging effect of terfenadine on rabbit myocardial tissue preparations. Biological & pharmaceutical bulletin 20040101
Anti-inflammatory activity of H1-receptor antagonists: review of recent experimental research. Current medical research and opinion 20040101
Comparative efficacy of cetirizine and fexofenadine in the treatment of chronic idiopathic urticaria. The Journal of dermatological treatment 20040101
Comparison of the combinations of fexofenadine-pseudoephedrine and loratadine-montelukast in the treatment of seasonal allergic rhinitis. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 20040101
Gateways to clinical trials. Methods and findings in experimental and clinical pharmacology 20040101
Randomized double-blind comparison of cetirizine and fexofenadine after pollen challenge in the Environmental Exposure Unit: duration of effect in subjects with seasonal allergic rhinitis. Allergy and asthma proceedings 20040101
Association between the number of coadministered P-glycoprotein inhibitors and serum digoxin levels in patients on therapeutic drug monitoring. BMC medicine 20040101
Quinolone safety and efficacy more important than potency. Emerging infectious diseases 20040101
Prolonged effect of an H1-receptor blocker antihistamine on the histamine content of white blood cells and mast cells. Cell biochemistry and function 20040101
Onset of action for the relief of allergic rhinitis symptoms with second-generation antihistamines. Allergy and asthma proceedings 20040101
QT prolongation in anaesthetized guinea-pigs: an experimental approach for preliminary screening of torsadogenicity of drugs and drug candidates. Journal of applied toxicology : JAT 20040101
Preventing serious drug interactions. FDA consumer 20040101
Suppressive activity of fexofenadine hydrochloride on the production of eosinophil chemoattractants from human nasal fibroblasts in vitro. Arzneimittel-Forschung 20040101
Development and validation of a liquid chromatographic method for fexofenadine hydrochloride in capsules. Journal of AOAC International 20040101
Improved precision and accuracy for high-performance liquid chromatography/Fourier transform ion cyclotron resonance mass spectrometric exact mass measurement of small molecules from the simultaneous and controlled introduction of internal calibrants via a second electrospray nebuliser. Rapid communications in mass spectrometry : RCM 20040101
Clinical study of the therapeutic efficacy and safety of emedastine difumarate versus terfenadine in the treatment of seasonal allergic rhinitis. Arzneimittel-Forschung 20040101
Fexofenadine HCl 60 mg/ pseudoephedrine HCl 120 mg has a 60-minute onset of action in the treatment of seasonal allergic rhinitis symptoms, as assessed in an allergen exposure unit. Allergy and asthma proceedings 20040101
[Serum sICAM-1 in patients suffering from allergic rhinitis treated with fexofenadine or fluticasone]. Pneumonologia i alergologia polska 20040101
Actual therapeutic management of allergic and hyperreactive nasal disorders. GMS current topics in otorhinolaryngology, head and neck surgery 20040101
Zebrafish embryos express an orthologue of HERG and are sensitive toward a range of QT-prolonging drugs inducing severe arrhythmia. Toxicology and applied pharmacology 20031215
Atrioventricular nodal ablation and His-bundle pacing: an acute canine model for proarrhythmic risk assesment. Journal of cardiovascular electrophysiology 20031201
Comparative study of acute effects of single doses of fexofenadine, olopatadine, d-chlorpheniramine and placebo on psychomotor function in healthy volunteers. Human psychopharmacology 20031201
Gateways to clinical trials. Methods and findings in experimental and clinical pharmacology 20031201
Effects of imatinib mesylate (STI571, Glivec) on the pharmacokinetics of simvastatin, a cytochrome p450 3A4 substrate, in patients with chronic myeloid leukaemia. British journal of cancer 20031117
Multiple transport mechanisms involved in the intestinal absorption and first-pass extraction of fexofenadine. Clinical pharmacology and therapeutics 20031101
A study comparing the inhibitory effects of single and repeated oral doses of ebastine and fexofenadine against histamine-induced skin reactivity. International archives of allergy and immunology 20031101
Effect of the second-generation antihistamine, fexofenadine, on cough reflex sensitivity and pulmonary function. British journal of clinical pharmacology 20031101
Mite-antigen induced immediate reactions in atopic dermatitis are inhibited by daily administration of fexofenadine. The Journal of dermatology 20031101
[Drug interactions. Mechanisms and clinical relevance]. Der Internist 20031101
Efficacy and safety profile of fexofenadine HCl: a unique therapeutic option in H1-receptor antagonist treatment. The Journal of allergy and clinical immunology 20031001
Effects of fexofenadine and other antihistamines on components of the allergic response: adhesion molecules. The Journal of allergy and clinical immunology 20031001
Effects of fexofenadine on T-cell function in a murine model of allergen-induced airway inflammation and hyperresponsiveness. The Journal of allergy and clinical immunology 20031001
Prospects for antihistamines in the treatment of asthma. The Journal of allergy and clinical immunology 20031001
Is 3-mm less drowsiness important? Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 20031001
Fexofenadine hydrochloride, 180 mg, exhibits equivalent efficacy to cetirizine, 10 mg, with less drowsiness in patients with moderate-to-severe seasonal allergic rhinitis. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 20031001
H1-receptor blocker antihistamine, terfenadine durably influences the glucocorticoid receptor, and lymphocyte histamine content of weanling rats. Pharmacological research 20030901
Terfenadine antagonism against interleukin-4-modulated gene expression of T cell cytokines. The Journal of investigative dermatology 20030901
Demethylation of radiolabelled dextromethorphan in rat microsomes and intact hepatocytes. European journal of biochemistry 20030901
[Observation on effect of integrative Chinese and Western medicine in treating acute attack of bronchial asthma]. Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine 20030901
Prediction of hERG potassium channel affinity by traditional and hologram qSAR methods. Bioorganic & medicinal chemistry letters 20030818
Sudden arrhythmia death syndrome: importance of the long QT syndrome. American family physician 20030801
Rapid assessment of P-glycoprotein inhibition and induction in vitro. Pharmaceutical research 20030801
Omalizumab, an anti-IgE antibody, in the treatment of adults and adolescents with perennial allergic rhinitis. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 20030801
The effects of fexofenadine on reaction time, decision-making, and driver behavior. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 20030801
Randomized, double-masked comparison of olopatadine ophthalmic solution, mometasone furoate monohydrate nasal spray, and fexofenadine hydrochloride tablets using the conjunctival and nasal allergen challenge models. Clinical therapeutics 20030801
RNA synthesis-dependent potentiation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate receptor-mediated toxicity by antihistamine terfenadine in cultured rat cerebellar neurons. Neuroscience letters 20030717
Inhibition of experimental allergic rhinitis by the n-butanol fraction from the anomalous fruits of Gleditsia sinensis. Biological & pharmaceutical bulletin 20030701
Herbal supplements and skin testing: the lack of effect of commonly used herbal supplements on histamine skin prick testing. Allergy 20030601
Supplementation of fexofenadine therapy with nedocromil sodium 2% ophthalmic solution to treat ocular symptoms of seasonal allergic conjunctivitis. Clinical & experimental ophthalmology 20030601
H1-antihistaminic activity of cetirizine and fexofenadine in allergic children. Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology 20030601
Pregnancy outcome after gestational exposure to loratadine or antihistamines: a prospective controlled cohort study. The Journal of allergy and clinical immunology 20030601
Addition of fexofenadine to a topical corticosteroid reduces the pruritus associated with atopic dermatitis in a 1-week randomized, multicentre, double-blind, placebo-controlled, parallel-group study. The British journal of dermatology 20030601
[Effects of clinically available drugs on the repolarization process of the heart assessed by the in vivo canine models]. Nihon yakurigaku zasshi. Folia pharmacologica Japonica 20030601
Relative potency of fexofenadine HCl 180 mg, loratadine 10 mg, and placebo using a skin test model of wheal-and-flare suppression. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 20030601
In vitro inhibition of human small intestinal and liver microsomal astemizole O-demethylation: different contribution of CYP2J2 in the small intestine and liver. Xenobiotica; the fate of foreign compounds in biological systems 20030601
[Clinical aspects of anti-inflammatory action of antihistamines]. Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego 20030601
Histamine H1 receptor antagonism by cetirizine in isolated guinea pig tissues: influence of receptor reserve and dissociation kinetics. European journal of pharmacology 20030530
Understanding the structure-activity relationship of the human ether-a-go-go-related gene cardiac K+ channel. A model for bad behavior. Journal of medicinal chemistry 20030522
Characterization of HERG potassium channel inhibition using CoMSiA 3D QSAR and homology modeling approaches. Bioorganic & medicinal chemistry letters 20030519
Voltage-dependent profile of human ether-a-go-go-related gene channel block is influenced by a single residue in the S6 transmembrane domain. Molecular pharmacology 20030501
Molecular mechanisms of G0/G1 cell-cycle arrest and apoptosis induced by terfenadine in human cancer cells. Molecular carcinogenesis 20030501
Effects of fexofenadine, diphenhydramine, and placebo on performance of the test of variables of attention (TOVA). Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 20030501
Characteristics of the antihistamine effect of TAK-427, a novel imidazopyridazine derivative. Inflammation research : official journal of the European Histamine Research Society ... [et al.] 20030501
A single-center, randomized, double-blind, placebo-controlled, crossover investigation of the effects of fexofenadine hydrochloride 180 mg alone and with alcohol, with hydroxyzine hydrochloride 50 mg as a positive internal control, on aspects of cognitive and psychomotor function related to driving a car. Clinical therapeutics 20030501
Comparison of in vitro P-glycoprotein screening assays: recommendations for their use in drug discovery. Journal of medicinal chemistry 20030424
Famotidine does not induce long QT syndrome: experimental evidence from in vitro and in vivo test systems. European journal of pharmacology 20030411
Fexofenadine is efficacious and safe in children (aged 6-11 years) with seasonal allergic rhinitis. The Journal of allergy and clinical immunology 20030401
Sedation and performance impairment of diphenhydramine and second-generation antihistamines: a meta-analysis. The Journal of allergy and clinical immunology 20030401
The effects of acute doses of fexofenadine, promethazine, and placebo on cognitive and psychomotor function in healthy Japanese volunteers. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 20030401
Photomutagenic properties of terfenadine as revealed by a stepwise photostability, phototoxicity and photomutagenicity testing approach. Photochemistry and photobiology 20030401
[H1 histamine antagonists]. Revue medicale de Bruxelles 20030401
Drugs that induce repolarization abnormalities cause bradycardia in zebrafish. Circulation 20030318
Decongestant effects of antihistamines: a class effect? The Journal of allergy and clinical immunology 20030301
Solar urticaria induced by infrared radiation. Clinical and experimental dermatology 20030301
Inhibitory effect of azelastine on allergic itch-associated response in mice sensitized with mosquito salivary glands extract. Journal of pharmacological sciences 20030301
Detection of proarrhythmia in the female rabbit heart: blinded validation. Journal of cardiovascular electrophysiology 20030301
Effect of fexofenadine hydrochloride on cedar pollinosis. Auris, nasus, larynx 20030201
Failure of cetirizine and fexofenadine to prevent motion sickness. The Annals of pharmacotherapy 20030201
Synthesis of eosinophil infiltration inhibitors with antihistaminic activity. Chemical & pharmaceutical bulletin 20030201
The effect of ketoconazole on the in vivo intestinal permeability of fexofenadine using a regional perfusion technique. British journal of clinical pharmacology 20030201
Comparative in vivo bioactivity of modern H1-antihistamines on AMP challenge in atopic asthma. The Journal of allergy and clinical immunology 20030201
The effects of single-dose fexofenadine, diphenhydramine, and placebo on cognitive performance in flight personnel. Aviation, space, and environmental medicine 20030201
Functional and pharmacological properties of canine ERG potassium channels. American journal of physiology. Heart and circulatory physiology 20030101
Blinded test in isolated female rabbit heart reliably identifies action potential duration prolongation and proarrhythmic drugs: importance of triangulation, reverse use dependence, and instability. Journal of cardiovascular pharmacology 20030101
Coordinate induction of both cytochrome P4503A and MDR1 by St John's wort in healthy subjects. Clinical pharmacology and therapeutics 20030101
Internal standard signal suppression by co-eluting analyte in isotope dilution LC-ESI-MS. The Analyst 20030101
Lopinavir/ritonavir: a review of its use in the management of HIV infection. Drugs 20030101
Pharmacogenetics--the horizon. Reviews in gastroenterological disorders 20030101
[Effect of fexofenadine--selective antagonist of histamine receptor (H1) on histamine-induced bronchoconstriction]. Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego 20030101
Assessing satisfaction with desloratadine and fexofenadine in allergy patients who report dissatisfaction with loratadine. BMC family practice 20030101
Antihistamines. Psychosomatics 20030101
Issues related to monitoring the safety of over-the-counter (OTC) medicines. Drug safety 20030101
Cellular and ionic basis for the sex-related difference in the manifestation of the Brugada syndrome and progressive conduction disease phenotypes. Journal of electrocardiology 20030101
Substrate dependent inhibition profiles of fourteen drugs on CYP3A4 activity measured by a high throughput LCMS/MS method with four probe drugs, midazolam, testosterone, nifedipine and terfenadine. Drug metabolism and pharmacokinetics 20030101
Receptor-dependent regulation of the CYP3A4 gene. Toxicology 20021227
Roles of histamine in regulation of arousal and cognition: functional neuroimaging of histamine H1 receptors in human brain. Life sciences 20021220
Inhibition of allergic dermal inflammation by the novel imidazopyridazine derivative TAK-427 in a guinea pig experimental model of eczema. The Journal of pharmacology and experimental therapeutics 20021201
Inhibitory effects of oral prednisolone and fexofenadine on skin responses by prick tests with histamine and compound 48/80. Journal of dermatological science 20021201
Facial swelling and eosinophilia in a 44-year-old woman. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 20021201
Effects of fexofenadine on the early response to nasal allergen challenge. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 20021201
Effects of supratherapeutic doses of ebastine and terfenadine on the QT interval. British journal of clinical pharmacology 20021201
Effect of fexofenadine, a mast cell blocker, in infertile men with significantly increased testicular mast cells. Asian journal of andrology 20021201
Development of neuroleptic agents: pharmacogenetics and current safety issues of regulatory concern. Dialogues in clinical neuroscience 20021201
The antihistamine fexofenadine does not affect I(Kr) currents in a case report of drug-induced cardiac arrhythmia. British journal of pharmacology 20021101
Fexofenadine transport in Caco-2 cells: inhibition with verapamil and ritonavir. Journal of clinical pharmacology 20021101
Clinical pharmacology of H1-antihistamines in the skin. The Journal of allergy and clinical immunology 20021101
Comparative study of some additives for the improvement of terfenadine performance. Die Pharmazie 20021101
Ionic and cellular basis for the predominance of the Brugada syndrome phenotype in males. Circulation 20021008
Effects of fexofenadine and desloratadine on subjective and objective measures of nasal congestion in seasonal allergic rhinitis. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 20021001
Aspirin-induced urticaria and angioedema, but not bronchoconstriction, associated with cysteinyl leukotriene overproduction in 2 patients with asthma. The Journal of allergy and clinical immunology 20021001
Data-mining analyses of pharmacovigilance signals in relation to relevant comparison drugs. European journal of clinical pharmacology 20021001
Review of fexofenadine in the treatment of chronic idiopathic urticaria. International journal of dermatology 20021001
The use of handheld computers in clinical trials. Controlled clinical trials 20021001
The relationship of clinical QT prolongation to outcome in the conscious dog using a beat-to-beat QT-RR interval assessment. The Journal of pharmacology and experimental therapeutics 20020801
The functional properties of the human ether-à-go-go-like (HELK2) K+ channel. The European journal of neuroscience 20020801
Molecular identification and characterisation of the human eag2 potassium channel. FEBS letters 20020731
Simultaneous determination of fexofenadine and its related compounds by HPLC. Journal of pharmaceutical and biomedical analysis 20020720
Chronic urticaria and angioedema. The New England journal of medicine 20020718
Role of lung inflammatory mediators as a cause of exercise-induced arterial hypoxemia in young athletes. Journal of applied physiology (Bethesda, Md. : 1985) 20020701
Fexofenadine modulates T-cell function, preventing allergen-induced airway inflammation and hyperresponsiveness. The Journal of allergy and clinical immunology 20020701
Onset of action, efficacy, and safety of fexofenadine 60 mg/pseudoephedrine 120 mg versus placebo in the Atlanta allergen exposure unit. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 20020701
Comparison of the efficacy of combined fluticasone propionate and olopatadine versus combined fluticasone propionate and fexofenadine for the treatment of allergic rhinoconjunctivitis induced by conjunctival allergen challenge. Clinical therapeutics 20020701
In vivo anti-inflammatory effects of fexofenadine in chronic idiopathic urticaria. Journal of the European Academy of Dermatology and Venereology : JEADV 20020701
Pharmacological rescue of human K(+) channel long-QT2 mutations: human ether-a-go-go-related gene rescue without block. Circulation 20020618
Next generation antihistamines: therapeutic rationale, accomplishments and advances. Expert opinion on investigational drugs 20020601
Are herbal products dietary supplements or drugs? An important question for public safety. Clinical pharmacology and therapeutics 20020601
Effect of St John's wort on the pharmacokinetics of fexofenadine. Clinical pharmacology and therapeutics 20020601
The Rx-to-OTC switch of Claritin, Allegra, and Zyrtec: an unprecedented FDA response to petitioners and the protection of public health. The American University law review 20020601
Delineation of the protective action of zinc sulfate on ulcerative colitis in rats. European journal of pharmacology 20020517
Three-dimensional quantitative structure-activity relationship for inhibition of human ether-a-go-go-related gene potassium channel. The Journal of pharmacology and experimental therapeutics 20020501
MDR1 gene polymorphisms and disposition of the P-glycoprotein substrate fexofenadine. British journal of clinical pharmacology 20020501
Evaluation of cytokines in nasal secretions after nasal antigen challenge: lack of influence of antihistamines. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 20020501
[Hay fever and asthma. Many of your patients have both]. MMW Fortschritte der Medizin 20020425
Sustained ER Ca2+ depletion suppresses protein synthesis and induces activation-enhanced cell death in mast cells. The Journal of biological chemistry 20020419
[Chronic idiopathic urticaria: effectiveness of fexofenadine. A double-blind, placebo controlled study with 21 patients]. Praxis 20020410
Intradermal cholinergic agonists induce itch-associated response via M3 muscarinic acetylcholine receptors in mice. Japanese journal of pharmacology 20020301
Cardiotoxicity of new antihistamines and cisapride. Toxicology letters 20020227
Antihistamines in late-phase clinical development for allergic disease. Expert opinion on investigational drugs 20020201
Proarrhythmic potential of halofantrine, terfenadine and clofilium in a modified in vivo model of torsade de pointes. British journal of pharmacology 20020201
A double-blind, randomized, single-dose, crossover comparison of levocetirizine with ebastine, fexofenadine, loratadine, mizolastine, and placebo: suppression of histamine-induced wheal-and-flare response during 24 hours in healthy male subjects. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 20020201
Are antihistamines useful in managing asthma? Current opinion in allergy and clinical immunology 20020201
Determination of fexofenadine in human plasma and urine by liquid chromatography-mass spectrometry. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20020125
Induction of multidrug resistance-1 and cytochrome P450 mRNAs in human mononuclear cells by rifampin. Drug metabolism and disposition: the biological fate of chemicals 20020101
Fruit juices inhibit organic anion transporting polypeptide-mediated drug uptake to decrease the oral availability of fexofenadine. Clinical pharmacology and therapeutics 20020101
Effects of antihistamines on leukotriene and cytokine release from dispersed nasal polyp cells. Arzneimittel-Forschung 20020101
Pharmacokinetic profile of zafirlukast. Clinical pharmacokinetics 20020101
Grapefruit juice reduces the oral bioavailability of fexofenadine but not desloratadine. Clinical pharmacokinetics 20020101
[Comparative antihistamine and anti-allergic effects of various antihistamine preparations]. Terapevticheskii arkhiv 20020101
Do standard doses of frequently prescribed drugs cause preventable adverse effects in women? Journal of the American Medical Women's Association (1972) 20020101
A comparison of once daily fexofenadine versus the combination of montelukast plus loratadine on domiciliary nasal peak flow and symptoms in seasonal allergic rhinitis. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 20020101
An evaluation of the effects of high-dose fexofenadine on the central nervous system: a double-blind, placebo-controlled study in healthy volunteers. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 20020101
Drug eruption and liver injury caused by terfenadine and oxatomide. European journal of dermatology : EJD 20020101
Potential cardiac toxicity of H1-antihistamines. Clinical allergy and immunology 20020101
[Risk of drug interactions. Combinations of drugs associated with ventricular arrhythmias]. Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion 20020101
[Effect of tedin on clinical and allergic indices of viral hepatitis in the presence of giardiasis]. Meditsinskaia parazitologiia i parazitarnye bolezni 20020101
Ketoconazole potentiates terfenadine-induced apoptosis in human Hep G2 cells through inhibition of cytochrome p450 3A4 activity. Journal of cellular biochemistry 20020101
Liquid chromatography/tandem mass spectrometric bioanalysis using normal-phase columns with aqueous/organic mobile phases - a novel approach of eliminating evaporation and reconstitution steps in 96-well SPE. Rapid communications in mass spectrometry : RCM 20020101
Effects of terfenadine and diphenhydramine on the CYP2D6 activity in healthy volunteers. European journal of drug metabolism and pharmacokinetics 20020101
The use of antihistamines in safety-critical jobs: a meeting report. Current medical research and opinion 20020101
Rapidly distinguishing reversible and irreversible CYP450 inhibitors by using fluorometric kinetic analyses. European journal of drug metabolism and pharmacokinetics 20020101
Inhibition of the histamine wheal by ebastine compared with cetirizine, fexofenadine and loratadine at steady state. Drugs under experimental and clinical research 20020101
Application of microtiter plate assay to evaluate inhibitory effects of various compounds on nine cytochrome P450 isoforms and to estimate their inhibition patterns. Drug metabolism and pharmacokinetics 20020101
Effects of serum albumin and liver cytosol on CYP2C9- and CYP3A4-mediated drug metabolism. Drug metabolism and pharmacokinetics 20020101
pH-metric solubility. 3. Dissolution titration template method for solubility determination. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20011201
Second generation antihistamines in the treatment of seasonal allergic rhinitis due to Parietaria and cypress pollen. Pharmacological research 20011201
Histamine and the classic antihistamines. Drug news & perspectives 20011201
Assay of terfenadine in pharmaceutical formulation and human plasma by adsorptive stripping voltammetry. Journal of pharmaceutical and biomedical analysis 20011101
Fexofenadine reduces nasal congestion in perennial allergic rhinitis. Allergy 20011101
Inhibition of depolarization-induced [3H]noradrenaline release from SH-SY5Y human neuroblastoma cells by some second-generation H(1) receptor antagonists through blockade of store-operated Ca(2+) channels (SOCs). Biochemical pharmacology 20011101
[3H]dofetilide binding to HERG transfected membranes: a potential high throughput preclinical screen. European journal of pharmacology 20011026
An amino acid residue whose change by mutation affects drug binding to the HERG channel. FEBS letters 20011012
Effects of a new antiallergic drug, VUF-K-8788, on infiltration of lung parenchyma by eosinophils in guinea pigs and eosinophil-adhesion to human umbilical vein endothelial cells (HUVEC). Biological & pharmaceutical bulletin 20011001
The costs of nonsedating antihistamine therapy for allergic rhinitis in managed care: an updated analysis. The American journal of managed care 20011001
Development and evaluation of high throughput functional assay methods for HERG potassium channel. Journal of biomolecular screening 20011001
Involvement of thromboxane A2 and peptide leukotrienes in early and late phase nasal blockage in a guinea pig model of allergic rhinitis. Inflammation research : official journal of the European Histamine Research Society ... [et al.] 20010901
Pharmacological characterization of the leukocyte kinetics after intranasal antigen challenge in a guinea pig model of allergic rhinitis. Inflammation research : official journal of the European Histamine Research Society ... [et al.] 20010901
Terfenadine-beta-Cyclodextrin inclusion complex with antihistaminic activity enhancement. Drug development and industrial pharmacy 20010901
Ugly wait at the counter. Insurer pushes to make allergy drugs nonprescription. Modern healthcare 20010806
Effects of supratherapeutic doses of ebastine and terfenadine on the QT interval. British journal of clinical pharmacology 20010801
Identification of functionally variant MDR1 alleles among European Americans and African Americans. Clinical pharmacology and therapeutics 20010801
Assessing the effect of intranasal steroids on growth. The Journal of allergy and clinical immunology 20010701
Safety of fexofenadine in children treated for seasonal allergic rhinitis. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 20010701
Evaluation of the safety of fexofenadine from experience gained in general practice use in England in 1997. European journal of clinical pharmacology 20010701
[Effect of olopatadine hydrochloride, a novel antiallergic agent, on the QT interval in dogs]. Nihon yakurigaku zasshi. Folia pharmacologica Japonica 20010601
[Seasonal allergic rhinitis. Nasal obstruction can also beh improved]. MMW Fortschritte der Medizin 20010503
The canine Purkinje fiber: an in vitro model system for acquired long QT syndrome and drug-induced arrhythmogenesis. Journal of cardiovascular pharmacology 20010501
Fexofenadine decreases sensitivity to and montelukast improves recovery from inhaled mannitol. American journal of respiratory and critical care medicine 20010501
Controlled comparison of the efficacy and safety of cetirizine 10 mg o.d. and fexofenadine 120 mg o.d. in reducing symptoms of seasonal allergic rhinitis. International archives of allergy and immunology 20010501
A descriptive analysis of the use and cost of new-generation antihistamines in the treatment of allergic rhinitis: a retrospective database analysis. The American journal of managed care 20010501
VUF-K-8788, a periphery-selective histamine H1 antagonist with anti-pruritic activities. Japanese journal of pharmacology 20010501
Roles of mast cells and histamine in mosquito bite-induced allergic itch-associated responses in mice. Japanese journal of pharmacology 20010501
Cooperativity of alpha-naphthoflavone in cytochrome P450 3A-dependent drug oxidation activities in hepatic and intestinal microsomes from mouse and human. Xenobiotica; the fate of foreign compounds in biological systems 20010501
Newer antihistamines. The Medical letter on drugs and therapeutics 20010430
Uptake and efflux of the peptidic delta-opioid receptor agonist. Neuroscience letters 20010406
Problems of heart rate correction in assessment of drug-induced QT interval prolongation. Journal of cardiovascular electrophysiology 20010401
Twenty-four hours of activity of cetirizine and fexofenadine in the skin. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 20010401
Drug-induced cholestasis. Seminars in gastrointestinal disease 20010401
Skin concentrations of H1-receptor antagonists. The Journal of allergy and clinical immunology 20010301
Loratadine and terfenadine interaction with nefazodone: Both antihistamines are associated with QTc prolongation. Clinical pharmacology and therapeutics 20010301
The effect of rifampin administration on the disposition of fexofenadine. Clinical pharmacology and therapeutics 20010301
Effect of hydroxyzine on the transport of etoposide in rat small intestine. Anti-cancer drugs 20010301
Fexofenadine hydrochloride--a new anti-histaminic drug. The Israel Medical Association journal : IMAJ 20010301
Pharmacokinetic and safety profile of desloratadine and fexofenadine when coadministered with azithromycin: a randomized, placebo-controlled, parallel-group study. Clinical therapeutics 20010301
Role of mast cells in antigen-induced airway inflammation and bronchial hyperresponsiveness in rats. Japanese journal of pharmacology 20010301
Inhibition of human CYP1A2 activity in vitro by methylxanthines: potent competitive inhibition by 8-phenyltheophylline. Xenobiotica; the fate of foreign compounds in biological systems 20010301
Fixed solar urticaria to visible light successfully treated with fexofenadine. Photodermatology, photoimmunology & photomedicine 20010201
Absence of nasal mucosal atrophy with fluticasone aqueous nasal spray. Archives of otolaryngology--head & neck surgery 20010201
Involvement of multiple human cytochromes P450 in the liver microsomal metabolism of astemizole and a comparison with terfenadine. British journal of clinical pharmacology 20010201
Multicenter study of the efficacy and safety of fexofenadine 60 mg. twice daily in 108 Thai patients with chronic idiopathic urticaria. Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20010201
Premedication with antihistamines may enhance efficacy of specific-allergen immunotherapy. The Journal of allergy and clinical immunology 20010101
Comparison of montelukast and fexofenadine for chronic idiopathic urticaria. Archives of dermatology 20010101
Suppression of the early and late cutaneous allergic responses using fexofenadine and montelukast. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 20010101
Safety of antihistamines in children. Drug safety 20010101
Design, synthesis and antihistaminic (H1)activity of some condensed 2-(substituted)arylaminoethylpyrimidin-4(3H)-ones. Arzneimittel-Forschung 20010101
Histamine-induced activation of human lung macrophages. International archives of allergy and immunology 20010101
Saquinavir soft gelatin capsule: a comparative safety review. Drug safety 20010101
Evaluation of drug-induced QT interval prolongation: implications for drug approval and labelling. Drug safety 20010101
Pharmacokinetic/pharmacodynamic assessment of the effects of E4031, cisapride, terfenadine and terodiline on monophasic action potential duration in dog. Xenobiotica; the fate of foreign compounds in biological systems 20010101
[The effect of second generation histamine antagonists on the heart]. Pneumonologia i alergologia polska 20010101
Delusion of worm infestation associated with clarithromycin in a patient on peritoneal dialysis. Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis 20010101
Dissociable effects of histamine H1 antagonists on reaction-time performance in rats. Pharmacology, biochemistry, and behavior 20010101
Impact of rhinitis on airway inflammation: biological and therapeutic implications. Respiratory research 20010101
Effect of oxatomide, an antiallergic agent, on QT interval in dogs. Arzneimittel-Forschung 20010101
[Efficacy and safety of fexofenadine and cetirizine in the treatment of allergic rhinitis]. Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993) 20010101
Antihistamines and the torsade de point in children with allergic rhinitis. European review for medical and pharmacological sciences 20010101
Emerging role of drug interaction studies in drug development: the good, the bad, and the unknown. Psychopharmacology bulletin 20010101
Pharmacological blockade of ERG K(+) channels and Ca(2+) influx through store-operated channels exerts opposite effects on intracellular Ca(2+) oscillations in pituitary GH(3) cells. Molecular pharmacology 20001101
A structural basis for drug-induced long QT syndrome. Proceedings of the National Academy of Sciences of the United States of America 20001024
Mechanism of terfenadine block of ATP-sensitive K(+) channels. British journal of pharmacology 20000801
Redox state dependency of HERGS631C channel pharmacology: relation to C-type inactivation. FEBS letters 20000526
Fexofenadine HCl is safe and effective for treatment of chronic idiopathic urticaria. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 20000501
Sedation with 'non-sedating' antihistamines: four prescription-event monitoring studies in general practice. BMJ (Clinical research ed.) 20000429
Severe cardiac arrhythmia on fexofenadine? Prescrire international 20000201
Loratadine blockade of K(+) channels in human heart: comparison with terfenadine under physiological conditions. The Journal of pharmacology and experimental therapeutics 20000101
Antiallergic effects of H1-receptor antagonists. Allergy 20000101
Specific inhibition of TH2-type cytokine production from human peripheral T cells by terfenadine in vitro. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 19990901
Fexofenadine and prolonged QT intervals. Nursing 19990901
Epinastine, a nonsedating histamine H1 receptor antagonist, has a negligible effect on HERG channel. European journal of pharmacology 19990625
Block of HERG potassium channels by the antihistamine astemizole and its metabolites desmethylastemizole and norastemizole. Journal of cardiovascular electrophysiology 19990601
Interplay between CYP3A-mediated metabolism and polarized efflux of terfenadine and its metabolites in intestinal epithelial Caco-2 (TC7) cell monolayers. Pharmaceutical research 19990501
QT lengthening and life-threatening arrhythmias associated with fexofenadine. Lancet (London, England) 19990320
Risk of ventricular arrhythmias associated with nonsedating antihistamine drugs. British journal of clinical pharmacology 19990301
Blockade of HERG and Kv1.5 by ketoconazole. The Journal of pharmacology and experimental therapeutics 19980801
Molecular basis for the lack of HERG K+ channel block-related cardiotoxicity by the H1 receptor blocker cetirizine compared with other second-generation antihistamines. Molecular pharmacology 19980701
Fexofenadine. Drugs 19980201
A mechanism for the proarrhythmic effects of cisapride (Propulsid): high affinity blockade of the human cardiac potassium channel HERG. FEBS letters 19971103
[Excessive terfenadine level due to drinking grapefruit juice]. Nederlands tijdschrift voor geneeskunde 19971011
Applications of primary human hepatocytes in the evaluation of pharmacokinetic drug-drug interactions: evaluation of model drugs terfenadine and rifampin. Cell biology and toxicology 19970701
Comparative effects of nonsedating histamine H1 receptor antagonists, ebastine and terfenadine, on human Kv1.5 channels. European journal of pharmacology 19970520
[Syncopes during simultaneous use of terfenadine and itraconazole]. Nederlands tijdschrift voor geneeskunde 19970510
A comparative pharmacokinetic-pharmacodynamic study of the electrocardiographic effects of epinastine and terfenadine in rats. The Journal of pharmacy and pharmacology 19970401
Selective biotransformation of the human immunodeficiency virus protease inhibitor saquinavir by human small-intestinal cytochrome P4503A4: potential contribution to high first-pass metabolism. Drug metabolism and disposition: the biological fate of chemicals 19970201
Torsades de pointes from terfenadine and sotalol given in combination. Pacing and clinical electrophysiology : PACE 19961001
Terfenadine induced coma mimicking structural brain disease. The Journal of the Association of Physicians of India 19961001
Terfenadine-induced cholestatic hepatitis. Lancet (London, England) 19960824
HERG, a primary human ventricular target of the nonsedating antihistamine terfenadine. Circulation 19960815
Blockade of HERG channels expressed in Xenopus oocytes by the histamine receptor antagonists terfenadine and astemizole. FEBS letters 19960429
Terfenadine overdose induced polymorphous ventricular tachycardia. Indian pediatrics 19951001
Probable terfenadine-fluoxetine-associated cardiac toxicity. The Annals of pharmacotherapy 19950901
Effect of terfenadine and budesonide on nasal symptoms, olfaction, and nasal airway patency following allergen challenge. Allergy 19950801
[Ventricular arrhythmia induced by terfenadine treatment]. Medicina clinica 19950204
Torsades de pointes associated with terfenadine in a case of liver cirrhosis and hepatocellular carcinoma. Internal medicine (Tokyo, Japan) 19950201
Torsades de pointes induced by erythromycin and terfenadine. The American journal of emergency medicine 19941101
Torsades de pointes ventricular tachycardia associated with terfenadine and paracetamol self medication. The New Zealand medical journal 19941012
Torsade de pointes induced by terfenadine in a patient with long QT syndrome. Journal of electrocardiology 19941001
Urinary retention as a result of administration of terfenadine. The Journal of allergy and clinical immunology 19940601
Benefit/risk ratio of the antihistamines (H1-receptor antagonists) terfenadine and chlorpheniramine in children. The Journal of pediatrics 19940601
Risk of developing life-threatening ventricular arrhythmia associated with tefenadine in comparison with over-the-counter antihistamines, ibuprofen and clemastine. The American journal of cardiology 19940215
Characteristics of P388/VMDRC.04, a simple, sensitive model for studying P-glycoprotein antagonists. Cancer research 19940201
Drug-induced torsades de pointes: a possible interaction of terfenadine and erythromycin. The Annals of pharmacotherapy 19940201
[Torsades de pointes caused by the association of terfenadine and erythromycin]. Annales de medecine interne 19940101
Torsades de pointes associated with astemizole (Hismanal) therapy. Archives of internal medicine 19931213
Potential terfenadine-fluoxetine interaction. The Annals of pharmacotherapy 19931101
Public health problems and the rapid estimation of the size of the population at risk. Torsades de pointes and the use of terfenadine and astemizole in The Netherlands. Pharmacy world & science : PWS 19931015
Syncope and cardiac arrhythmia due to an interaction between itraconazole and terfenadine. The American journal of medicine 19931001
Is QT interval prolongation harmful? A regulatory perspective. The American journal of cardiology 19930826
The effect of antihistamines on the immediate allergic response: a comparative review. Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 19930601
Cutaneous IgE-mediated inflammatory lesion size is inhibited by an H1 antagonist (terfenadine) while mediator release is unaffected in vivo and in vitro. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 19930501
[A new cause of torsades de pointes: combination of terfenadine and troleandomycin]. Annales de cardiologie et d'angeiologie 19930501
Terfenadine-induced tremor. Annals of neurology 19930201
Torsades de pointes after terfenadine-itraconazole interaction. BMJ (Clinical research ed.) 19930116
Erythromycin and ketoconazole (Nizoral) associated with terfenadine (Seldane)-induced ventricular arrhythmias. General dentistry 19930101
The effect of terfenadine on the immediate and late-phase reactions mediated by immunoglobulin E. International archives of allergy and immunology 19930101
[Treatment with terfenadine and ketoconazole or itraconazole can cause torsades de pointes ventricular tachycardia]. Duodecim; laaketieteellinen aikakauskirja 19930101
Torsades de Pointes after treatment with terfenadine and ketoconazole. European heart journal 19920701
Terfenadine use associated with ventricular dysrhythmias. Critical care nurse 19920201
Torsades de pointes occurring in association with terfenadine use. JAMA 19901205
Antihistaminic activity and side effect profile of epinastine and terfenadine in healthy volunteers. International journal of clinical pharmacology, therapy, and toxicology 19901201
Effects of azatadine, terfenadine, and astemizole on allergen-induced nasal provocation. Annals of allergy 19900201
Prolongation of simple and choice reaction times in a double-blind comparison of twice-daily hydroxyzine versus terfenadine. The Journal of allergy and clinical immunology 19890901
[Therapy of acute and chronic urticaria and of Quincke's edema]. Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis 19890516
Comparative study of astemizole and terfenadine in the treatment of chronic idiopathic urticaria. A randomized double-blind study of 40 patients. Annals of allergy 19890401
'In vivo' and 'in vitro' evaluation of four antihistamines (astemizole, azatadine, mequitazine, terfenadine). Allergologia et immunopathologia 19890101
A comparison of acrivastine versus terfenadine and placebo in the treatment of chronic idiopathic urticaria. The Journal of international medical research 19890101
Evaluation of the antimuscarinic activity of atropine, terfenadine and mequitazine in healthy volunteers. British journal of clinical pharmacology 19880101
Pharmacologic analysis of LY188695 (KB-2413), 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)-benzimidazole difumarate, a potent histamine1 receptor antagonist. Agents and actions 19870201
Double-blind comparison of astemizole and terfenadine in the treatment of chronic urticaria. Pharmatherapeutica 19860101
[Comparison of astemizole and terfenadine in the treatment of chronic urticaria. A randomized double-blind study of 40 patients]. Zeitschrift fur Hautkrankheiten 19850101
Clinical pharmacokinetics of H1-receptor antagonists (the antihistamines). Clinical pharmacokinetics 19850101
Properties